date,datetime,title,summary,url,source,search_query,raw_content,finbert_sentiment,finbert_label,finbert_confidence,distilbert_sentiment,distilbert_label,distilbert_confidence,vader_compound,vader_positive,vader_negative,vader_neutral,textblob_polarity,textblob_subjectivity,ensemble_sentiment,confidence,fda_milestone_type,milestone_confidence,milestone_keywords_found,drug_specific,company_specific,importance_score,semantic_score
2020-06-11,2020-06-11 07:00:00,Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection) - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5"" target=""_blank"">Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5,Google News,Biocon Semglee FDA approval,"Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection) - PR Newswire <a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5"" target=""_blank"">Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.0,neutral,0.595608115196228,0.0,neutral,0.0,0.7351,0.181,0.0,0.819,0.0,0.0,0.0,0.6653540575981141,approval_process,0.8257113993167877,['FDA approval'],True,True,26,0.6514227986335754
2021-07-29,2021-07-29 07:00:00,New Day For Diabetes Patients As FDA Approves First-Ever Interchangeable Biosimilar - BioSpace,"<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxPWFE5cDVJQmQ3a2p4MTdMc0ZyVWtkb0FYbnVtNmUwME1iQlVkS3EwSnJXaFZPbWc2X2xqVlY2NmZITnh4Ui1qcUE3eU9vcVBKT0tDU0VnZXpvUG9DMnB6WEMwUFFIMU9aVDFGV25SWW9LMlBEdXpEdTBkUDNWanJWa2JVaHVTOTlITzh2aXdvMVN3TjFYdnM1UmN1SQ?oc=5"" target=""_blank"">New Day For Diabetes Patients As FDA Approves First-Ever Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpace</font>",https://news.google.com/rss/articles/CBMimwFBVV95cUxPWFE5cDVJQmQ3a2p4MTdMc0ZyVWtkb0FYbnVtNmUwME1iQlVkS3EwSnJXaFZPbWc2X2xqVlY2NmZITnh4Ui1qcUE3eU9vcVBKT0tDU0VnZXpvUG9DMnB6WEMwUFFIMU9aVDFGV25SWW9LMlBEdXpEdTBkUDNWanJWa2JVaHVTOTlITzh2aXdvMVN3TjFYdnM1UmN1SQ?oc=5,Google News,Biocon Semglee FDA approval,"New Day For Diabetes Patients As FDA Approves First-Ever Interchangeable Biosimilar - BioSpace <a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxPWFE5cDVJQmQ3a2p4MTdMc0ZyVWtkb0FYbnVtNmUwME1iQlVkS3EwSnJXaFZPbWc2X2xqVlY2NmZITnh4Ui1qcUE3eU9vcVBKT0tDU0VnZXpvUG9DMnB6WEMwUFFIMU9aVDFGV25SWW9LMlBEdXpEdTBkUDNWanJWa2JVaHVTOTlITzh2aXdvMVN3TjFYdnM1UmN1SQ?oc=5"" target=""_blank"">New Day For Diabetes Patients As FDA Approves First-Ever Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpace</font>",0.5201907753944397,positive,0.5201907753944397,0.0,neutral,0.0,0.6597,0.184,0.0,0.816,0.06818181818181818,0.22727272727272727,0.29725187165396555,0.4160241978587526,approval_process,0.7528555393218994,['FDA approval'],False,False,11,0.5057110786437988
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News,Biocon Semglee FDA approval,"FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.7366463541984558,positive,0.7366463541984558,0.0,neutral,0.0,0.6597,0.184,0.0,0.816,0.1,0.19166666666666665,0.420940773827689,0.49878211806615197,approval_process,0.7800931334495544,['FDA approval'],True,False,21,0.5601862668991089
2021-07-29,2021-07-29 07:00:00,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5,Google News,Biocon Semglee FDA approval,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business <a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",0.5844137072563171,positive,0.5844137072563171,0.0,neutral,0.0,0.6597,0.172,0.0,0.828,0.0,0.0,0.3339506898607526,0.6220568536281585,approval_process,0.8245938718318939,['FDA approval'],False,True,16,0.6491877436637878
2022-01-03,2022-01-03 08:00:00,New FDA Approved Insulin Marks Another Win for Insulin Affordability - diaTribe,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUkc2TjFlczdDaDhVR3BoTzFUVnk1d19INXNxVFVJaFMyUllpaHR4Tng1b3ZIU0NQek9URUNkalhyQVA2LVM5OHZWcUVybFJhSFNKYnFOcnBBOTNDazgwOWlrVi1xaVEyZ2pTR0VtcWVuYWxoZ01OWTNCWnhGZjFkSVE4WmpGeGVSZ0hGR3gtaF9SMzJXUGN0RkN5U0JmRmxWc1JVWlczZnQzZw?oc=5"" target=""_blank"">New FDA Approved Insulin Marks Another Win for Insulin Affordability</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUkc2TjFlczdDaDhVR3BoTzFUVnk1d19INXNxVFVJaFMyUllpaHR4Tng1b3ZIU0NQek9URUNkalhyQVA2LVM5OHZWcUVybFJhSFNKYnFOcnBBOTNDazgwOWlrVi1xaVEyZ2pTR0VtcWVuYWxoZ01OWTNCWnhGZjFkSVE4WmpGeGVSZ0hGR3gtaF9SMzJXUGN0RkN5U0JmRmxWc1JVWlczZnQzZw?oc=5,Google News,Biocon Semglee FDA approval,"New FDA Approved Insulin Marks Another Win for Insulin Affordability - diaTribe <a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUkc2TjFlczdDaDhVR3BoTzFUVnk1d19INXNxVFVJaFMyUllpaHR4Tng1b3ZIU0NQek9URUNkalhyQVA2LVM5OHZWcUVybFJhSFNKYnFOcnBBOTNDazgwOWlrVi1xaVEyZ2pTR0VtcWVuYWxoZ01OWTNCWnhGZjFkSVE4WmpGeGVSZ0hGR3gtaF9SMzJXUGN0RkN5U0JmRmxWc1JVWlczZnQzZw?oc=5"" target=""_blank"">New FDA Approved Insulin Marks Another Win for Insulin Affordability</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",0.9000426530838013,positive,0.9000426530838013,0.0,neutral,0.0,0.9217,0.398,0.0,0.602,0.4340909090909091,0.3136363636363636,0.5143100874764578,0.7519445207249035,approval_process,0.7626034021377563,['FDA approval'],False,False,11,0.5252068042755127
2021-07-29,2021-07-29 07:00:00,Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon Semglee FDA approval,"Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.7746681571006775,0.0,neutral,0.0,0.4767,0.11,0.0,0.89,0.13333333333333333,0.13333333333333333,0.0,0.46156716347800364,approval_process,0.7767300009727478,['FDA approval'],True,True,26,0.5534600019454956
2021-07-29,2021-07-29 07:00:00,Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar... - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon Semglee FDA approval,"Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar... - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.7698100805282593,positive,0.7698100805282593,0.0,neutral,0.0,0.6597,0.172,0.0,0.828,0.16666666666666666,0.2222222222222222,0.4398914745875767,0.532058915731642,approval_process,0.7473947405815125,['FDA approval'],True,True,26,0.4947894811630249
2020-06-12,2020-06-12 07:00:00,"Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection - Express Pharma","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.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?oc=5,Google News,Biocon Semglee FDA approval,"Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection - Express Pharma <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.70448237657547,positive,0.70448237657547,0.0,neutral,0.0,0.7351,0.171,0.0,0.829,0.0,0.0,0.40256135804312565,0.719791188287735,approval_process,0.8278532922267914,['FDA approval'],True,True,26,0.6557065844535828
2021-08-02,2021-08-02 07:00:00,Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5"" target=""_blank"">Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5,Google News,Biocon Semglee FDA approval,"Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5"" target=""_blank"">Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",-0.9178489446640015,negative,0.9178489446640015,0.0,neutral,0.0,0.8885,0.266,0.0,0.734,-0.05,0.1,-0.5244851112365723,0.6187829815546672,approval_process,0.7204506099224091,['FDA approval'],False,False,11,0.4409012198448181
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News,Biocon Semglee FDA approval,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.8734995126724243,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.05,0.05,0.0,0.4617497563362122,regulatory_issues,0.5561130583286286,['manufacturing issue'],False,True,14,0.3122261166572571
2020-09-01,2020-09-01 07:00:00,Semglee: Insulin Glargine “Biosimilar” Approved for Diabetes in the US - Diabetes In Control,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOSml6X0d0cjlzclN4UWFKRU9kZlc3c3lSMXBUNG9SR19BVDNmdW41TWxpcHk5RjJad3VpVGlFSnU1YXpXd2Z3VlUtVzZNNGtGbGVLeXE2a09WZjVlZEgyMC1JalJxcFVJQURjQlZxVnh6SEpyWko3aXVlOWtNN2xOeG1TUnlqSjJGTG5OV3dYcnlGUDZwWnlZaURTdUhwdWhXRUlGbA?oc=5"" target=""_blank"">Semglee: Insulin Glargine “Biosimilar” Approved for Diabetes in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOSml6X0d0cjlzclN4UWFKRU9kZlc3c3lSMXBUNG9SR19BVDNmdW41TWxpcHk5RjJad3VpVGlFSnU1YXpXd2Z3VlUtVzZNNGtGbGVLeXE2a09WZjVlZEgyMC1JalJxcFVJQURjQlZxVnh6SEpyWko3aXVlOWtNN2xOeG1TUnlqSjJGTG5OV3dYcnlGUDZwWnlZaURTdUhwdWhXRUlGbA?oc=5,Google News,Biocon Semglee clinical trial,"Semglee: Insulin Glargine “Biosimilar” Approved for Diabetes in the US - Diabetes In Control <a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOSml6X0d0cjlzclN4UWFKRU9kZlc3c3lSMXBUNG9SR19BVDNmdW41TWxpcHk5RjJad3VpVGlFSnU1YXpXd2Z3VlUtVzZNNGtGbGVLeXE2a09WZjVlZEgyMC1JalJxcFVJQURjQlZxVnh6SEpyWko3aXVlOWtNN2xOeG1TUnlqSjJGTG5OV3dYcnlGUDZwWnlZaURTdUhwdWhXRUlGbA?oc=5"" target=""_blank"">Semglee: Insulin Glargine “Biosimilar” Approved for Diabetes in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",0.0,neutral,0.8588917851448059,0.0,neutral,0.0,0.6808,0.177,0.0,0.823,0.0,0.0,0.0,0.769845892572403,approval_process,0.779649943113327,['biosimilar approval'],True,False,21,0.559299886226654
2018-12-31,2018-12-31 01:41:28,Table 3 . Biosimilar Insulins in Clinical Trials. - researchgate.net,"<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxPMXhmOV9lakV1c2hyYl9oTjB6cXRlaG1pQ1pMSGh0X0J1Zkh5VFFQeVZXX0ZQTDF6bWFpdnpYVE5SWTR4VDZNVzloMm9qMElrQzBXYkhKWWxsVzdUN2hPWFU5V2gzOXdLYTVla2NSQTlYY1J3cUNyLW1fbW5wZC1qUjJRM2pqX1V0VmdhMWZhcnBUM0E?oc=5"" target=""_blank"">Table 3 . Biosimilar Insulins in Clinical Trials.</a>&nbsp;&nbsp;<font color=""#6f6f6f"">researchgate.net</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxPMXhmOV9lakV1c2hyYl9oTjB6cXRlaG1pQ1pMSGh0X0J1Zkh5VFFQeVZXX0ZQTDF6bWFpdnpYVE5SWTR4VDZNVzloMm9qMElrQzBXYkhKWWxsVzdUN2hPWFU5V2gzOXdLYTVla2NSQTlYY1J3cUNyLW1fbW5wZC1qUjJRM2pqX1V0VmdhMWZhcnBUM0E?oc=5,Google News,Biocon Semglee clinical trial,"Table 3 . Biosimilar Insulins in Clinical Trials. - researchgate.net <a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxPMXhmOV9lakV1c2hyYl9oTjB6cXRlaG1pQ1pMSGh0X0J1Zkh5VFFQeVZXX0ZQTDF6bWFpdnpYVE5SWTR4VDZNVzloMm9qMElrQzBXYkhKWWxsVzdUN2hPWFU5V2gzOXdLYTVla2NSQTlYY1J3cUNyLW1fbW5wZC1qUjJRM2pqX1V0VmdhMWZhcnBUM0E?oc=5"" target=""_blank"">Table 3 . Biosimilar Insulins in Clinical Trials.</a>&nbsp;&nbsp;<font color=""#6f6f6f"">researchgate.net</font>",0.0,neutral,0.9394456744194031,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9394456744194031,clinical_trials,0.9136222124099731,"['clinical trial', 'clinical data']",True,False,18,0.4272444248199463
2019-12-03,2019-12-03 08:00:00,Biocon gets FDA approval to produce pegfilgrastim in India - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5"" target=""_blank"">Biocon gets FDA approval to produce pegfilgrastim in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon gets FDA approval to produce pegfilgrastim in India - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5"" target=""_blank"">Biocon gets FDA approval to produce pegfilgrastim in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.8464288711547852,positive,0.8464288711547852,0.0,neutral,0.0,0.7351,0.22,0.0,0.78,0.0,0.0,0.48367364065987717,0.7907644355773926,approval_process,0.8222135603427887,['FDA approval'],False,True,16,0.6444271206855774
2017-09-11,2017-09-11 07:00:00,Biocon insulin plant in Malaysia wins EU manufacturing approval - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxONzk5OUh6M19yUmNVOWdDY2JfN3BCbVBqZXdxMVZjN3pmNWpJeWUzejZfU1JkaG5PWEc0M3ZBeF8yb0pZZ2NhME82QWowcThmLWgwZVc5dllDRG1EYnB3TDdjaFZRRTFSSWh6X2dWVjc5aVY5eGQtQXNIMzFuSDRlSi1leFVWTFAwalppWWtlNV9hazNQUmdCSXM5VmU5d3ZIZG5jNVp3?oc=5"" target=""_blank"">Biocon insulin plant in Malaysia wins EU manufacturing approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxONzk5OUh6M19yUmNVOWdDY2JfN3BCbVBqZXdxMVZjN3pmNWpJeWUzejZfU1JkaG5PWEc0M3ZBeF8yb0pZZ2NhME82QWowcThmLWgwZVc5dllDRG1EYnB3TDdjaFZRRTFSSWh6X2dWVjc5aVY5eGQtQXNIMzFuSDRlSi1leFVWTFAwalppWWtlNV9hazNQUmdCSXM5VmU5d3ZIZG5jNVp3?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon insulin plant in Malaysia wins EU manufacturing approval - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxONzk5OUh6M19yUmNVOWdDY2JfN3BCbVBqZXdxMVZjN3pmNWpJeWUzejZfU1JkaG5PWEc0M3ZBeF8yb0pZZ2NhME82QWowcThmLWgwZVc5dllDRG1EYnB3TDdjaFZRRTFSSWh6X2dWVjc5aVY5eGQtQXNIMzFuSDRlSi1leFVWTFAwalppWWtlNV9hazNQUmdCSXM5VmU5d3ZIZG5jNVp3?oc=5"" target=""_blank"">Biocon insulin plant in Malaysia wins EU manufacturing approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.9015867114067078,positive,0.9015867114067078,0.0,neutral,0.0,0.8885,0.333,0.0,0.667,0.19999999999999998,0.13333333333333333,0.5151924065181187,0.6633622371355693,approval_process,0.7873438596725464,['drug approval'],False,True,16,0.5746877193450928
2021-07-28,2021-07-28 07:00:00,FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5,Google News,Semglee FDA approval 2021,"FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS <a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",0.5834283232688904,positive,0.5834283232688904,0.0,neutral,0.0,0.6597,0.172,0.0,0.828,0.16666666666666666,0.2222222222222222,0.3333876132965088,0.4699316633118524,approval_process,0.7574118375778198,['FDA approval'],True,False,21,0.5148236751556396
2021-07-29,2021-07-29 07:00:00,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5,Google News,Semglee FDA approval 2021,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive <a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",0.6338136792182922,positive,0.6338136792182922,0.0,neutral,0.0,0.6597,0.213,0.0,0.787,0.16666666666666666,0.2222222222222222,0.3621792452675956,0.486726781961653,approval_process,0.7657920122146606,['FDA approval'],True,False,21,0.5315840244293213
2021-07-29,2021-07-29 07:00:00,Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin - Beyond Type 1,"<a href=""https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5"" target=""_blank"">Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5,Google News,Semglee FDA approval 2021,"Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin - Beyond Type 1 <a href=""https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5"" target=""_blank"">Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",0.8389886021614075,positive,0.8389886021614075,0.0,neutral,0.0,0.7351,0.212,0.0,0.788,0.16666666666666666,0.2222222222222222,0.4794220583779471,0.5802517562760248,approval_process,0.7598708868026733,['FDA approval'],True,False,21,0.5197417736053467
2021-07-28,2021-07-28 07:00:00,FDA Approves First Interchangeable Biosimilar Insulin - Medscape,"<a href=""https://news.google.com/rss/articles/CBMiVkFVX3lxTE5YZUwzUFNjZ2c3X0dJXzh6RDNib2gzOHZKa0poeXIzcjd2Y2Raemd3dWltdUh6dkhlcTNTLWR4ZS1yMG1TbjRUSlU3dlpJUXBtWldReWh3?oc=5"" target=""_blank"">FDA Approves First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medscape</font>",https://news.google.com/rss/articles/CBMiVkFVX3lxTE5YZUwzUFNjZ2c3X0dJXzh6RDNib2gzOHZKa0poeXIzcjd2Y2Raemd3dWltdUh6dkhlcTNTLWR4ZS1yMG1TbjRUSlU3dlpJUXBtWldReWh3?oc=5,Google News,Semglee FDA approval 2021,"FDA Approves First Interchangeable Biosimilar Insulin - Medscape <a href=""https://news.google.com/rss/articles/CBMiVkFVX3lxTE5YZUwzUFNjZ2c3X0dJXzh6RDNib2gzOHZKa0poeXIzcjd2Y2Raemd3dWltdUh6dkhlcTNTLWR4ZS1yMG1TbjRUSlU3dlpJUXBtWldReWh3?oc=5"" target=""_blank"">FDA Approves First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medscape</font>",0.5064266920089722,positive,0.5064266920089722,0.0,neutral,0.0,0.6597,0.278,0.0,0.722,0.16666666666666666,0.2222222222222222,0.28938668114798405,0.4442644528918796,approval_process,0.7955113649368286,['FDA approval'],True,False,21,0.5910227298736572
2021-08-03,2021-08-03 07:00:00,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5,Google News,Semglee FDA approval 2021,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control <a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",0.6942455172538757,positive,0.6942455172538757,0.0,neutral,0.0,0.4767,0.119,0.0,0.881,0.0,0.0,0.3967117241450718,0.5854727586269379,approval_process,0.8041950464248657,['FDA approval'],True,False,21,0.6083900928497314
2021-08-04,2021-08-04 07:00:00,"FDA Approvals Roundup: Semglee, Saphnelo, Uptravi - Regulatory Affairs Professionals Society | RAPS","<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQb3JBVkpMS3Q4TlIydHdYNGpPa29CelpOejFSVXFwQ0hobzdNOGdYTlc4c2ZPbXpFTDZxYU1lbGl6SzBvOTZZUFRTMnRzbHJxbDB4S0xVYWdrOGhSdE9oTGFpYUlOSFo4bkdrUjdSem0wVVBkUVNadUNLX3dGTU53bi1QQWtvS1M2LU5GU2tHbE9odG1XZ3cxNWU5cW55cUtVVnpNTUZJOEJzZw?oc=5"" target=""_blank"">FDA Approvals Roundup: Semglee, Saphnelo, Uptravi</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxQb3JBVkpMS3Q4TlIydHdYNGpPa29CelpOejFSVXFwQ0hobzdNOGdYTlc4c2ZPbXpFTDZxYU1lbGl6SzBvOTZZUFRTMnRzbHJxbDB4S0xVYWdrOGhSdE9oTGFpYUlOSFo4bkdrUjdSem0wVVBkUVNadUNLX3dGTU53bi1QQWtvS1M2LU5GU2tHbE9odG1XZ3cxNWU5cW55cUtVVnpNTUZJOEJzZw?oc=5,Google News,Semglee FDA approval 2021,"FDA Approvals Roundup: Semglee, Saphnelo, Uptravi - Regulatory Affairs Professionals Society | RAPS <a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQb3JBVkpMS3Q4TlIydHdYNGpPa29CelpOejFSVXFwQ0hobzdNOGdYTlc4c2ZPbXpFTDZxYU1lbGl6SzBvOTZZUFRTMnRzbHJxbDB4S0xVYWdrOGhSdE9oTGFpYUlOSFo4bkdrUjdSem0wVVBkUVNadUNLX3dGTU53bi1QQWtvS1M2LU5GU2tHbE9odG1XZ3cxNWU5cW55cUtVVnpNTUZJOEJzZw?oc=5"" target=""_blank"">FDA Approvals Roundup: Semglee, Saphnelo, Uptravi</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",0.0,neutral,0.9213662147521973,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9213662147521973,approval_process,1.0,"['FDA approval', 'drug approval', 'biosimilar approval', 'interchangeable designation', 'marketing authorization', 'regulatory approval', 'FDA clearance']",True,False,26,0.7140103578567505
2021-07-29,2021-07-29 07:00:00,FDA approves first interchangeable biosimilar insulin product - European Pharmaceutical Review,"<a href=""https://news.google.com/rss/articles/CBMiuwFBVV95cUxQZkd1U3ZvajNsUEs2Rkd2UzQ1QWMyci0wc1pBQnk4a3gtaXEwN0hqRlpDbHM5c0dYNGtJZU1YRFp2T0hKaElKUDByWnF2dkVuc0g2cklBaWp1enpfSUE1UFF4ZW1rdWRiRjk4Sks3ZkpwLVRnYnlqblJocEFvUzNaLTUyRGZYR2RUeGw4Q3YxT2FOWnFkM0QydjZzZjduTFBRMnVwV3psaVh4M25aUFFSeWxPbmxaeXQ4RlFZ?oc=5"" target=""_blank"">FDA approves first interchangeable biosimilar insulin product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">European Pharmaceutical Review</font>",https://news.google.com/rss/articles/CBMiuwFBVV95cUxQZkd1U3ZvajNsUEs2Rkd2UzQ1QWMyci0wc1pBQnk4a3gtaXEwN0hqRlpDbHM5c0dYNGtJZU1YRFp2T0hKaElKUDByWnF2dkVuc0g2cklBaWp1enpfSUE1UFF4ZW1rdWRiRjk4Sks3ZkpwLVRnYnlqblJocEFvUzNaLTUyRGZYR2RUeGw4Q3YxT2FOWnFkM0QydjZzZjduTFBRMnVwV3psaVh4M25aUFFSeWxPbmxaeXQ4RlFZ?oc=5,Google News,Semglee FDA approval 2021,"FDA approves first interchangeable biosimilar insulin product - European Pharmaceutical Review <a href=""https://news.google.com/rss/articles/CBMiuwFBVV95cUxQZkd1U3ZvajNsUEs2Rkd2UzQ1QWMyci0wc1pBQnk4a3gtaXEwN0hqRlpDbHM5c0dYNGtJZU1YRFp2T0hKaElKUDByWnF2dkVuc0g2cklBaWp1enpfSUE1UFF4ZW1rdWRiRjk4Sks3ZkpwLVRnYnlqblJocEFvUzNaLTUyRGZYR2RUeGw4Q3YxT2FOWnFkM0QydjZzZjduTFBRMnVwV3psaVh4M25aUFFSeWxPbmxaeXQ4RlFZ?oc=5"" target=""_blank"">FDA approves first interchangeable biosimilar insulin product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">European Pharmaceutical Review</font>",0.6842642426490784,positive,0.6842642426490784,0.0,neutral,0.0,0.6597,0.213,0.0,0.787,0.125,0.16666666666666666,0.3910081386566162,0.4896547475496928,approval_process,0.8047485947608948,['FDA approval'],True,False,21,0.6094971895217896
2017-09-18,2017-09-18 07:00:00,"Biocon's Vizag API plant clears US FDA inspection, shares up - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's Vizag API plant clears US FDA inspection, shares up</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon's Vizag API plant clears US FDA inspection, shares up - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's Vizag API plant clears US FDA inspection, shares up</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.773132860660553,positive,0.773132860660553,0.0,neutral,0.0,0.6124,0.259,0.0,0.741,0.0,0.0,0.4417902060917446,0.6927664303302765,regulatory_review,0.7162017345428466,['FDA inspection'],False,True,15,0.5324034690856934
2021-12-23,2021-12-23 08:00:00,Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval - NDTV,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval - NDTV <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV</font>",0.0,neutral,0.8966063857078552,0.0,neutral,0.0,0.4767,0.103,0.0,0.897,0.0,0.0,0.0,0.6866531928539277,approval_process,0.7706487774848938,['regulatory approval'],False,True,16,0.5412975549697876
2020-12-14,2020-12-14 08:00:00,Biocon Biologics and Mylan Receive CHMP Recommendation for Approval of Biosimilar Insulin Aspart - Biocon,"<a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQN0czcVl2cDZKamNrOU1JYkZjUjROMGloeUNzclNuVWwxTWpQS01sME51cUtya0c0cThNUXhWNERiNm96OUd1Vk9pZXE1bE00YnhWbzN5RzQyaWdlNHJQXzFDSXBCbW9ybXRpZG1JajVBU0ZvRkNjN2Z0LWhPWGtvbVk5TFlfcERrdDhmWVJnZEhBTmVhYVFhU0o4SVhpeDhfb2lNa3JQRDVxckxQQmdENUk1bUVvdUhYSWRTTA?oc=5"" target=""_blank"">Biocon Biologics and Mylan Receive CHMP Recommendation for Approval of Biosimilar Insulin Aspart</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMivAFBVV95cUxQN0czcVl2cDZKamNrOU1JYkZjUjROMGloeUNzclNuVWwxTWpQS01sME51cUtya0c0cThNUXhWNERiNm96OUd1Vk9pZXE1bE00YnhWbzN5RzQyaWdlNHJQXzFDSXBCbW9ybXRpZG1JajVBU0ZvRkNjN2Z0LWhPWGtvbVk5TFlfcERrdDhmWVJnZEhBTmVhYVFhU0o4SVhpeDhfb2lNa3JQRDVxckxQQmdENUk1bUVvdUhYSWRTTA?oc=5,Google News,Biocon insulin biosimilar,"Biocon Biologics and Mylan Receive CHMP Recommendation for Approval of Biosimilar Insulin Aspart - Biocon <a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQN0czcVl2cDZKamNrOU1JYkZjUjROMGloeUNzclNuVWwxTWpQS01sME51cUtya0c0cThNUXhWNERiNm96OUd1Vk9pZXE1bE00YnhWbzN5RzQyaWdlNHJQXzFDSXBCbW9ybXRpZG1JajVBU0ZvRkNjN2Z0LWhPWGtvbVk5TFlfcERrdDhmWVJnZEhBTmVhYVFhU0o4SVhpeDhfb2lNa3JQRDVxckxQQmdENUk1bUVvdUhYSWRTTA?oc=5"" target=""_blank"">Biocon Biologics and Mylan Receive CHMP Recommendation for Approval of Biosimilar Insulin Aspart</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.8103600144386292,positive,0.8103600144386292,0.0,neutral,0.0,0.7351,0.181,0.0,0.819,0.0,0.0,0.46306286539350233,0.7727300072193146,approval_process,0.8078452348709106,['FDA approval'],True,True,26,0.6156904697418213
2017-12-04,2017-12-04 08:00:00,US FDA approves Mylan and Biocon’s Ogivri - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMiekFVX3lxTE12Mk5vQm9zOU9WVGpla2tIbjNQSDljNGtESExOdmtfYnQ0S0VSeGNIWGpRZ1JIV3Rya0IyYkNfN1ZRQ3Y2Y1BXWGI5TDBwWk0yNGZDcy0yU2VwLXNVZlJ2QlNybmhiZk9SWFVacmU5aDZncURSS1hpYUpR0gF_QVVfeXFMTk1hY2ZhQmp3Q0psc1NWbEhBMEd6X1ViQzhveEhSd0JhcXNmeHNzTjZEaTl1NkJScVVqdmJjUVFxdTRJSlM0b0Jqd2xwanhCVzR5WGJFMDNkb2s4N01PVzVDRmRHbHV6VzBvRlI5RjN2cU9idTY2WHYwYmNheG55TQ?oc=5"" target=""_blank"">US FDA approves Mylan and Biocon’s Ogivri</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMiekFVX3lxTE12Mk5vQm9zOU9WVGpla2tIbjNQSDljNGtESExOdmtfYnQ0S0VSeGNIWGpRZ1JIV3Rya0IyYkNfN1ZRQ3Y2Y1BXWGI5TDBwWk0yNGZDcy0yU2VwLXNVZlJ2QlNybmhiZk9SWFVacmU5aDZncURSS1hpYUpR0gF_QVVfeXFMTk1hY2ZhQmp3Q0psc1NWbEhBMEd6X1ViQzhveEhSd0JhcXNmeHNzTjZEaTl1NkJScVVqdmJjUVFxdTRJSlM0b0Jqd2xwanhCVzR5WGJFMDNkb2s4N01PVzVDRmRHbHV6VzBvRlI5RjN2cU9idTY2WHYwYmNheG55TQ?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"US FDA approves Mylan and Biocon’s Ogivri - Express Pharma <a href=""https://news.google.com/rss/articles/CBMiekFVX3lxTE12Mk5vQm9zOU9WVGpla2tIbjNQSDljNGtESExOdmtfYnQ0S0VSeGNIWGpRZ1JIV3Rya0IyYkNfN1ZRQ3Y2Y1BXWGI5TDBwWk0yNGZDcy0yU2VwLXNVZlJ2QlNybmhiZk9SWFVacmU5aDZncURSS1hpYUpR0gF_QVVfeXFMTk1hY2ZhQmp3Q0psc1NWbEhBMEd6X1ViQzhveEhSd0JhcXNmeHNzTjZEaTl1NkJScVVqdmJjUVFxdTRJSlM0b0Jqd2xwanhCVzR5WGJFMDNkb2s4N01PVzVDRmRHbHV6VzBvRlI5RjN2cU9idTY2WHYwYmNheG55TQ?oc=5"" target=""_blank"">US FDA approves Mylan and Biocon’s Ogivri</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.6854794025421143,positive,0.6854794025421143,0.0,neutral,0.0,0.6597,0.231,0.0,0.769,0.0,0.0,0.391702515738351,0.6725897012710571,approval_process,0.8323659300804138,['FDA approval'],False,True,16,0.6647318601608276
2025-04-10,2025-04-10 07:00:00,FDA Approves Biocon Biologics' Bevacizumab Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxOLXg5SmhvUG5XNFdIOUhnbUZIaEgzSnZjR01VRlhRTzVrQnBNX2NpakRSZ2lLejRPWm1WaUM0TEhTTFh0Z0xSVEUtVnMxOTJZVWNhTVM0cExOM0ltUktxTGtBam9VX3A1V1lLdzVXRDlHU3BGSjl6dlozTEplUjRFTkNyVGY5X3V5Y0laRHA5TXljbGlfSHRiWmdB?oc=5"" target=""_blank"">FDA Approves Biocon Biologics' Bevacizumab Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxOLXg5SmhvUG5XNFdIOUhnbUZIaEgzSnZjR01VRlhRTzVrQnBNX2NpakRSZ2lLejRPWm1WaUM0TEhTTFh0Z0xSVEUtVnMxOTJZVWNhTVM0cExOM0ltUktxTGtBam9VX3A1V1lLdzVXRDlHU3BGSjl6dlozTEplUjRFTkNyVGY5X3V5Y0laRHA5TXljbGlfSHRiWmdB?oc=5,Google News,Biocon Semglee FDA approval,"FDA Approves Biocon Biologics' Bevacizumab Biosimilar - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxOLXg5SmhvUG5XNFdIOUhnbUZIaEgzSnZjR01VRlhRTzVrQnBNX2NpakRSZ2lLejRPWm1WaUM0TEhTTFh0Z0xSVEUtVnMxOTJZVWNhTVM0cExOM0ltUktxTGtBam9VX3A1V1lLdzVXRDlHU3BGSjl6dlozTEplUjRFTkNyVGY5X3V5Y0laRHA5TXljbGlfSHRiWmdB?oc=5"" target=""_blank"">FDA Approves Biocon Biologics' Bevacizumab Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.5271222591400146,0.0,neutral,0.0,0.6597,0.231,0.0,0.769,-0.05,0.05,0.0,0.4122740863800049,approval_process,0.8330743610858917,['FDA approval'],False,True,16,0.6661487221717834
2024-04-04,2024-04-04 07:00:00,Eye on Pharma: Biosimilar Ozempic; Celltrion Omalizumab Biosimilar Submission - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxPeTNpMHRoenZwaGZ6bWZQTHEzZm1PbllFczRSQmFyQUVfZUJETnZtZWZ6RVp4b2FPMHpkc2gtTFJOVzJOTDN5Q2RhUE45di1tMEhNcml5TGhHS3YtODJLYWpFeUZGeG9qNDUxX2QzOTdxVEJkRHVyYmZnNXRJaWxxamZndVQ5cjBWU1NDbGtHakprSWFFVEhIa0EwNVRCZHVJY2w4blI2eTNQUTc0M1Jwa3pzNnU4ODdtVXdlQVZtMkJuRmJMTVNkVXd5YW1GOWh3dHQ0?oc=5"" target=""_blank"">Eye on Pharma: Biosimilar Ozempic; Celltrion Omalizumab Biosimilar Submission</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMi0wFBVV95cUxPeTNpMHRoenZwaGZ6bWZQTHEzZm1PbllFczRSQmFyQUVfZUJETnZtZWZ6RVp4b2FPMHpkc2gtTFJOVzJOTDN5Q2RhUE45di1tMEhNcml5TGhHS3YtODJLYWpFeUZGeG9qNDUxX2QzOTdxVEJkRHVyYmZnNXRJaWxxamZndVQ5cjBWU1NDbGtHakprSWFFVEhIa0EwNVRCZHVJY2w4blI2eTNQUTc0M1Jwa3pzNnU4ODdtVXdlQVZtMkJuRmJMTVNkVXd5YW1GOWh3dHQ0?oc=5,Google News,Biocon Semglee FDA submission,"Eye on Pharma: Biosimilar Ozempic; Celltrion Omalizumab Biosimilar Submission - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxPeTNpMHRoenZwaGZ6bWZQTHEzZm1PbllFczRSQmFyQUVfZUJETnZtZWZ6RVp4b2FPMHpkc2gtTFJOVzJOTDN5Q2RhUE45di1tMEhNcml5TGhHS3YtODJLYWpFeUZGeG9qNDUxX2QzOTdxVEJkRHVyYmZnNXRJaWxxamZndVQ5cjBWU1NDbGtHakprSWFFVEhIa0EwNVRCZHVJY2w4blI2eTNQUTc0M1Jwa3pzNnU4ODdtVXdlQVZtMkJuRmJMTVNkVXd5YW1GOWh3dHQ0?oc=5"" target=""_blank"">Eye on Pharma: Biosimilar Ozempic; Celltrion Omalizumab Biosimilar Submission</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.9325511455535889,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.05,0.05,0.0,0.49127557277679446,application_phase,1.0,"['FDA submission', 'BLA submission', 'NDA submission']",False,False,9,0.49551036953926086
2022-11-18,2022-11-18 08:00:00,FDA approves Rezvoglar as second ‘interchangeable’ insulin biosimilar - BioPharma Dive,"<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxQdDlLRjh5NkZkdF9pZl9PODg2cDA1NXZoWGxRUjNlNEdkV0toQnFrS2h5MllSeWk0cjZHTjk1T2VFeU1JWTdNV3lhMzNpOXl6TXZ6dVRMcnRSRzVJSEdibjluTF9QamVlQlZBcDdzcVFBZTlpUVRQM3VIWG9WS19sdzNJOUNBLTFqYkxuYXZJMXMwQ1FSb0E2RjRrTQ?oc=5"" target=""_blank"">FDA approves Rezvoglar as second ‘interchangeable’ insulin biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioPharma Dive</font>",https://news.google.com/rss/articles/CBMimwFBVV95cUxQdDlLRjh5NkZkdF9pZl9PODg2cDA1NXZoWGxRUjNlNEdkV0toQnFrS2h5MllSeWk0cjZHTjk1T2VFeU1JWTdNV3lhMzNpOXl6TXZ6dVRMcnRSRzVJSEdibjluTF9QamVlQlZBcDdzcVFBZTlpUVRQM3VIWG9WS19sdzNJOUNBLTFqYkxuYXZJMXMwQ1FSb0E2RjRrTQ?oc=5,Google News,Biocon Semglee clinical trial,"FDA approves Rezvoglar as second ‘interchangeable’ insulin biosimilar - BioPharma Dive <a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxQdDlLRjh5NkZkdF9pZl9PODg2cDA1NXZoWGxRUjNlNEdkV0toQnFrS2h5MllSeWk0cjZHTjk1T2VFeU1JWTdNV3lhMzNpOXl6TXZ6dVRMcnRSRzVJSEdibjluTF9QamVlQlZBcDdzcVFBZTlpUVRQM3VIWG9WS19sdzNJOUNBLTFqYkxuYXZJMXMwQ1FSb0E2RjRrTQ?oc=5"" target=""_blank"">FDA approves Rezvoglar as second ‘interchangeable’ insulin biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioPharma Dive</font>",0.643006443977356,positive,0.643006443977356,0.0,neutral,0.0,0.6597,0.213,0.0,0.787,0.0,0.0,0.36743225370134625,0.651353221988678,approval_process,0.7571117877960205,['FDA approval'],False,False,11,0.514223575592041
2025-04-10,2025-04-10 07:00:00,"Biocon Biologics secures US FDA approval for Biosimilar Bevacizumab, JOBEVNE - Express Pharma","<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxOczFIemVhMFg4bFNuUVZVb2pFb1FpZ1U2N0xzOE90bXhhOWdIYzFpZDNhUWVrZ2p2QU9WdUJ2czRxTjhpTFJDUGcxWmtRS3pTdVgzbzNWSzE0azc0OW9EejUwRWtFWURMTjU0elhKek1iX1hCX3ZzVHotd0pUV2FXckh4TGpTY2MwamxsMTRFYzdWaGwwMzc3WFdPXy1oVjJxSW9FNHAzSkvSAa4BQVVfeXFMUEhYYklLRFBhRW9sMmNrdDhQVnJkc0Jnc01SQ0VfRWMtR01aZENKOUJ0UkZyXzJOcEo4MkswVHZsdEQzMmljTlZJQkVSVFkwMWtvVm5vUmpTMUdrUFR3a21SVEZBZU9GdTVQcGZMZFJIU0NuSEREdVItc0NlM3lNU2NWY2s2MTdJYW9lUlB3LWJCY1ZRLVg0bk9feUdCMkhUdmcxVmQ0Q0licGM3UTJn?oc=5"" target=""_blank"">Biocon Biologics secures US FDA approval for Biosimilar Bevacizumab, JOBEVNE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxOczFIemVhMFg4bFNuUVZVb2pFb1FpZ1U2N0xzOE90bXhhOWdIYzFpZDNhUWVrZ2p2QU9WdUJ2czRxTjhpTFJDUGcxWmtRS3pTdVgzbzNWSzE0azc0OW9EejUwRWtFWURMTjU0elhKek1iX1hCX3ZzVHotd0pUV2FXckh4TGpTY2MwamxsMTRFYzdWaGwwMzc3WFdPXy1oVjJxSW9FNHAzSkvSAa4BQVVfeXFMUEhYYklLRFBhRW9sMmNrdDhQVnJkc0Jnc01SQ0VfRWMtR01aZENKOUJ0UkZyXzJOcEo4MkswVHZsdEQzMmljTlZJQkVSVFkwMWtvVm5vUmpTMUdrUFR3a21SVEZBZU9GdTVQcGZMZFJIU0NuSEREdVItc0NlM3lNU2NWY2s2MTdJYW9lUlB3LWJCY1ZRLVg0bk9feUdCMkhUdmcxVmQ0Q0licGM3UTJn?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon Biologics secures US FDA approval for Biosimilar Bevacizumab, JOBEVNE - Express Pharma <a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxOczFIemVhMFg4bFNuUVZVb2pFb1FpZ1U2N0xzOE90bXhhOWdIYzFpZDNhUWVrZ2p2QU9WdUJ2czRxTjhpTFJDUGcxWmtRS3pTdVgzbzNWSzE0azc0OW9EejUwRWtFWURMTjU0elhKek1iX1hCX3ZzVHotd0pUV2FXckh4TGpTY2MwamxsMTRFYzdWaGwwMzc3WFdPXy1oVjJxSW9FNHAzSkvSAa4BQVVfeXFMUEhYYklLRFBhRW9sMmNrdDhQVnJkc0Jnc01SQ0VfRWMtR01aZENKOUJ0UkZyXzJOcEo4MkswVHZsdEQzMmljTlZJQkVSVFkwMWtvVm5vUmpTMUdrUFR3a21SVEZBZU9GdTVQcGZMZFJIU0NuSEREdVItc0NlM3lNU2NWY2s2MTdJYW9lUlB3LWJCY1ZRLVg0bk9feUdCMkhUdmcxVmQ0Q0licGM3UTJn?oc=5"" target=""_blank"">Biocon Biologics secures US FDA approval for Biosimilar Bevacizumab, JOBEVNE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.5463883280754089,positive,0.5463883280754089,0.0,neutral,0.0,0.8689,0.329,0.0,0.671,0.0,0.0,0.3122219017573765,0.7076441640377045,approval_process,0.8261142373085022,['FDA approval'],False,True,16,0.6522284746170044
2025-04-10,2025-04-10 07:00:00,"Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio - PR Newswire","<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQcG5TMThQVFo3VWx4b2R4aWtKYVFYLWV4REk5SFc1M01TdTJ1SzZiU1AyUlEzNVBNNzUxYVduVUFoeDFUMm5TRUoxWU1LXzl3bm90UkZuLUtuTm5IRXpranhkc0RDckRBbkIxREVRNmNlejRpdlVuaXFGeTAweTRzQktueE5SS3RVc3ItTG52UHhnVkZ3V1lpV2xIQ0otVEU5Vko4T1FSVlhTdElPRFdTdUttSGhxOXpIYUo4MEoxWWtaWXpvNDJ0clNhQnV6VC1sWjJPMHlIZVBrd1JjVGhOWDl0ZXBXYzNmSFJjdTdleWxHdVExUXVtX3Nn?oc=5"" target=""_blank"">Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxQcG5TMThQVFo3VWx4b2R4aWtKYVFYLWV4REk5SFc1M01TdTJ1SzZiU1AyUlEzNVBNNzUxYVduVUFoeDFUMm5TRUoxWU1LXzl3bm90UkZuLUtuTm5IRXpranhkc0RDckRBbkIxREVRNmNlejRpdlVuaXFGeTAweTRzQktueE5SS3RVc3ItTG52UHhnVkZ3V1lpV2xIQ0otVEU5Vko4T1FSVlhTdElPRFdTdUttSGhxOXpIYUo4MEoxWWtaWXpvNDJ0clNhQnV6VC1sWjJPMHlIZVBrd1JjVGhOWDl0ZXBXYzNmSFJjdTdleWxHdVExUXVtX3Nn?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio - PR Newswire <a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQcG5TMThQVFo3VWx4b2R4aWtKYVFYLWV4REk5SFc1M01TdTJ1SzZiU1AyUlEzNVBNNzUxYVduVUFoeDFUMm5TRUoxWU1LXzl3bm90UkZuLUtuTm5IRXpranhkc0RDckRBbkIxREVRNmNlejRpdlVuaXFGeTAweTRzQktueE5SS3RVc3ItTG52UHhnVkZ3V1lpV2xIQ0otVEU5Vko4T1FSVlhTdElPRFdTdUttSGhxOXpIYUo4MEoxWWtaWXpvNDJ0clNhQnV6VC1sWjJPMHlIZVBrd1JjVGhOWDl0ZXBXYzNmSFJjdTdleWxHdVExUXVtX3Nn?oc=5"" target=""_blank"">Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.9183073043823242,positive,0.9183073043823242,0.0,neutral,0.0,0.7351,0.162,0.0,0.838,0.0,0.0,0.5247470310756138,0.8267036521911622,approval_process,0.8269002437591553,['FDA approval'],False,True,16,0.6538004875183105
2023-10-09,2023-10-09 07:00:00,FDA hits Biocon's insulin copycat with a CRL as plant awaits pre-approval inspection - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxPNmZTQWVscmJKUVNMTmtvei0wVWs3UjBIODNmZGd3ZWhwazdBQ19zdHAwaVFoNzdvWGpaeDloc2tqSzZVVFdJRms2WDg5TW1DTTlDTGZWMWM5WWhkaGRHUjd5alhtOFZsb1FWN0tZdTdBU3RNOC1ESUtIWWFfWml6eTJDWGg3QkZmQjdvSk1OeThSVy05MW9YNGtyLTRyTmFJM0kyWGZKR2tSUGVycDB0SmdOZEVWSGs?oc=5"" target=""_blank"">FDA hits Biocon's insulin copycat with a CRL as plant awaits pre-approval inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxPNmZTQWVscmJKUVNMTmtvei0wVWs3UjBIODNmZGd3ZWhwazdBQ19zdHAwaVFoNzdvWGpaeDloc2tqSzZVVFdJRms2WDg5TW1DTTlDTGZWMWM5WWhkaGRHUjd5alhtOFZsb1FWN0tZdTdBU3RNOC1ESUtIWWFfWml6eTJDWGg3QkZmQjdvSk1OeThSVy05MW9YNGtyLTRyTmFJM0kyWGZKR2tSUGVycDB0SmdOZEVWSGs?oc=5,Google News,Biocon insulin biosimilar FDA,"FDA hits Biocon's insulin copycat with a CRL as plant awaits pre-approval inspection - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxPNmZTQWVscmJKUVNMTmtvei0wVWs3UjBIODNmZGd3ZWhwazdBQ19zdHAwaVFoNzdvWGpaeDloc2tqSzZVVFdJRms2WDg5TW1DTTlDTGZWMWM5WWhkaGRHUjd5alhtOFZsb1FWN0tZdTdBU3RNOC1ESUtIWWFfWml6eTJDWGg3QkZmQjdvSk1OeThSVy05MW9YNGtyLTRyTmFJM0kyWGZKR2tSUGVycDB0SmdOZEVWSGs?oc=5"" target=""_blank"">FDA hits Biocon's insulin copycat with a CRL as plant awaits pre-approval inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.7395175695419312,negative,0.7395175695419312,0.0,neutral,0.0,0.1531,0.085,0.0,0.915,0.0,0.0,-0.4225814683096749,0.4463087847709656,regulatory_review,1.0,"['FDA inspection', 'pre-approval inspection']",False,True,15,0.5846893787384033
2023-02-13,2023-02-13 08:00:00,Biocon's proposed Avastin biosim hit with FDA rejection after failed plant inspection - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxNNlo5VXZOMTRueS0tQUdmR0prdWd6NDVHQzcyWWt1dGtJeVVCeERUX0l4TVJzRXl0YUt3Nl9wZVAtcFVnenZoQlJfY0hPaXZBVElQZzMzS1ZNV1oyRDJQSkl0QzNscGM4SExDZUhYaDAza1NCLXUyR0M5Uzg2UVZFTmR6aDBXRldqSWV4ZFFUQm5wRGRpVTZtbDRYSUl0Vi1VbklrY09VTjVpQTNQNWxSZFdGVS1zRUdPV3JwNg?oc=5"" target=""_blank"">Biocon's proposed Avastin biosim hit with FDA rejection after failed plant inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMivAFBVV95cUxNNlo5VXZOMTRueS0tQUdmR0prdWd6NDVHQzcyWWt1dGtJeVVCeERUX0l4TVJzRXl0YUt3Nl9wZVAtcFVnenZoQlJfY0hPaXZBVElQZzMzS1ZNV1oyRDJQSkl0QzNscGM4SExDZUhYaDAza1NCLXUyR0M5Uzg2UVZFTmR6aDBXRldqSWV4ZFFUQm5wRGRpVTZtbDRYSUl0Vi1VbklrY09VTjVpQTNQNWxSZFdGVS1zRUdPV3JwNg?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon's proposed Avastin biosim hit with FDA rejection after failed plant inspection - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxNNlo5VXZOMTRueS0tQUdmR0prdWd6NDVHQzcyWWt1dGtJeVVCeERUX0l4TVJzRXl0YUt3Nl9wZVAtcFVnenZoQlJfY0hPaXZBVElQZzMzS1ZNV1oyRDJQSkl0QzNscGM4SExDZUhYaDAza1NCLXUyR0M5Uzg2UVZFTmR6aDBXRldqSWV4ZFFUQm5wRGRpVTZtbDRYSUl0Vi1VbklrY09VTjVpQTNQNWxSZFdGVS1zRUdPV3JwNg?oc=5"" target=""_blank"">Biocon's proposed Avastin biosim hit with FDA rejection after failed plant inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.8460134863853455,negative,0.8460134863853455,0.0,neutral,0.0,-0.9274,0.0,0.343,0.657,-0.3333333333333333,0.19999999999999998,-0.4834362779344831,0.7022489399062263,regulatory_review,0.7313665568828582,['FDA inspection'],False,True,15,0.5627331137657166
2022-07-06,2022-07-06 07:00:00,Viatris starts yet another insulin biosimilar recall over potential missing labels - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxOM3gxV3NwMUNuWFhnSmZlUXFvZHdib1d0MklwczV1UWdCSkdrRXZYOVpMdi1NblhuVVNoMFNOSzdrS1l6alFzc1JxN3J4d0FXN3BrNlJsaFJ5dE82aldzMURNWk54emhOaUFjODUyVkVhcGxEWHlQTEJHWWdUMnYySlVXc1NxaElOZ0YtMXlJZ0doVlhWOVhyMWlwbHBucklwTGIzdmtzYm5RbTE4UWVmQndZdWVmMndsalE?oc=5"" target=""_blank"">Viatris starts yet another insulin biosimilar recall over potential missing labels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxOM3gxV3NwMUNuWFhnSmZlUXFvZHdib1d0MklwczV1UWdCSkdrRXZYOVpMdi1NblhuVVNoMFNOSzdrS1l6alFzc1JxN3J4d0FXN3BrNlJsaFJ5dE82aldzMURNWk54emhOaUFjODUyVkVhcGxEWHlQTEJHWWdUMnYySlVXc1NxaElOZ0YtMXlJZ0doVlhWOVhyMWlwbHBucklwTGIzdmtzYm5RbTE4UWVmQndZdWVmMndsalE?oc=5,Google News,Biocon insulin biosimilar FDA,"Viatris starts yet another insulin biosimilar recall over potential missing labels - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxOM3gxV3NwMUNuWFhnSmZlUXFvZHdib1d0MklwczV1UWdCSkdrRXZYOVpMdi1NblhuVVNoMFNOSzdrS1l6alFzc1JxN3J4d0FXN3BrNlJsaFJ5dE82aldzMURNWk54emhOaUFjODUyVkVhcGxEWHlQTEJHWWdUMnYySlVXc1NxaElOZ0YtMXlJZ0doVlhWOVhyMWlwbHBucklwTGIzdmtzYm5RbTE4UWVmQndZdWVmMndsalE?oc=5"" target=""_blank"">Viatris starts yet another insulin biosimilar recall over potential missing labels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.7730820775032043,negative,0.7730820775032043,0.0,neutral,0.0,-0.5267,0.0,0.145,0.855,-0.08,0.41999999999999993,-0.44176118714468815,0.4599273591677348,regulatory_issues,0.6038116008043289,['recall'],False,False,9,0.40762320160865784
2023-10-07,2023-10-07 07:00:00,USFDA rejects proposed Biocon's Insulin Aspart application in CRL - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA rejects proposed Biocon's Insulin Aspart application in CRL</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon insulin biosimilar FDA,"USFDA rejects proposed Biocon's Insulin Aspart application in CRL - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA rejects proposed Biocon's Insulin Aspart application in CRL</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.5522840619087219,negative,0.5522840619087219,0.0,neutral,0.0,-0.7506,0.0,0.225,0.775,0.0,0.0,-0.31559089251926964,0.6514420309543609,application_phase,0.6456154823303223,['drug application'],False,True,14,0.49123096466064453
2022-11-17,2022-11-17 08:00:00,FDA approves second interchangeable insulin glargine biosimilar for patients with diabetes - Healio,"<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxOTEc1aEdUZmZ0Z2VDUDc1c1R1bGROYXhyZE9YQmcyRjJ2bTdSYlExVUx3cFBUcEpKZTkxYzZtYkJtUGdyTFlDTHAzSFBONHZaOWh3YkJDb0tsU09fYnNzTXUyc3JmS2g2V2dHdnh6ZFNlcmF6RUYzU1VKQ0I4Ri1yNGdOekxLMnFSckpXYXprWHpFUVl5ejQyeC1WWWJTZXRBc0FFdUVDN1VJT2RrLTZPeHZEWlloVzBKbWNDTEpjenNFNGc?oc=5"" target=""_blank"">FDA approves second interchangeable insulin glargine biosimilar for patients with diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Healio</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxOTEc1aEdUZmZ0Z2VDUDc1c1R1bGROYXhyZE9YQmcyRjJ2bTdSYlExVUx3cFBUcEpKZTkxYzZtYkJtUGdyTFlDTHAzSFBONHZaOWh3YkJDb0tsU09fYnNzTXUyc3JmS2g2V2dHdnh6ZFNlcmF6RUYzU1VKQ0I4Ri1yNGdOekxLMnFSckpXYXprWHpFUVl5ejQyeC1WWWJTZXRBc0FFdUVDN1VJT2RrLTZPeHZEWlloVzBKbWNDTEpjenNFNGc?oc=5,Google News,Semglee FDA approval 2021,"FDA approves second interchangeable insulin glargine biosimilar for patients with diabetes - Healio <a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxOTEc1aEdUZmZ0Z2VDUDc1c1R1bGROYXhyZE9YQmcyRjJ2bTdSYlExVUx3cFBUcEpKZTkxYzZtYkJtUGdyTFlDTHAzSFBONHZaOWh3YkJDb0tsU09fYnNzTXUyc3JmS2g2V2dHdnh6ZFNlcmF6RUYzU1VKQ0I4Ri1yNGdOekxLMnFSckpXYXprWHpFUVl5ejQyeC1WWWJTZXRBc0FFdUVDN1VJT2RrLTZPeHZEWlloVzBKbWNDTEpjenNFNGc?oc=5"" target=""_blank"">FDA approves second interchangeable insulin glargine biosimilar for patients with diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Healio</font>",0.7059784531593323,positive,0.7059784531593323,0.0,neutral,0.0,0.6597,0.184,0.0,0.816,0.0,0.0,0.40341625894818983,0.6828392265796661,approval_process,0.7826697826385498,['FDA approval'],False,False,11,0.5653395652770996
2022-11-18,2022-11-18 08:00:00,FDA Approves Second Interchangeable Lantus Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxQc2Q0OWlxR2hTVVNzcUNWNGx1S01OWThjNzRmUnQybDdaeldnTXp3QzhtaFYyWi1FQkNmRmd6ejRLOTFuaWdVdUN0WjJJQWpuUTJNd1YzdjJVRVpRcGdkX3RNU1FQc0UzU1VMRE12YXRTbFlxRDRNNnB6cjlnWHE1Y2VvT1k2MVBudWFKUHpFc1FYdU13TDEwS2Y1UXpMY1ZkTHpj?oc=5"" target=""_blank"">FDA Approves Second Interchangeable Lantus Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxQc2Q0OWlxR2hTVVNzcUNWNGx1S01OWThjNzRmUnQybDdaeldnTXp3QzhtaFYyWi1FQkNmRmd6ejRLOTFuaWdVdUN0WjJJQWpuUTJNd1YzdjJVRVpRcGdkX3RNU1FQc0UzU1VMRE12YXRTbFlxRDRNNnB6cjlnWHE1Y2VvT1k2MVBudWFKUHpFc1FYdU13TDEwS2Y1UXpMY1ZkTHpj?oc=5,Google News,Semglee FDA approval 2021,"FDA Approves Second Interchangeable Lantus Biosimilar - Managed Healthcare Executive <a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxQc2Q0OWlxR2hTVVNzcUNWNGx1S01OWThjNzRmUnQybDdaeldnTXp3QzhtaFYyWi1FQkNmRmd6ejRLOTFuaWdVdUN0WjJJQWpuUTJNd1YzdjJVRVpRcGdkX3RNU1FQc0UzU1VMRE12YXRTbFlxRDRNNnB6cjlnWHE1Y2VvT1k2MVBudWFKUHpFc1FYdU13TDEwS2Y1UXpMY1ZkTHpj?oc=5"" target=""_blank"">FDA Approves Second Interchangeable Lantus Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",0.6096327900886536,positive,0.6096327900886536,0.0,neutral,0.0,0.6597,0.231,0.0,0.769,0.0,0.0,0.3483615943363735,0.6346663950443268,approval_process,0.8089102506637573,['FDA approval'],False,False,11,0.6178205013275146
2023-02-12,2023-02-12 08:00:00,Biocon says USFDA issued CRL for Bevacizumab license application - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon says USFDA issued CRL for Bevacizumab license application</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon BLA submission,"Biocon says USFDA issued CRL for Bevacizumab license application - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon says USFDA issued CRL for Bevacizumab license application</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.799424946308136,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.799424946308136,application_phase,0.5678276956081391,['IND application'],False,True,14,0.3356553912162781
2024-09-28,2024-09-28 07:00:00,US FDA concludes inspection of Biocon Biologics’ Insulins Facility in Malaysia - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">US FDA concludes inspection of Biocon Biologics’ Insulins Facility in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"US FDA concludes inspection of Biocon Biologics’ Insulins Facility in Malaysia - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">US FDA concludes inspection of Biocon Biologics’ Insulins Facility in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.6682268977165222,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.6682268977165222,regulatory_review,0.7549721717834472,['FDA inspection'],False,True,15,0.6099443435668945
2024-09-19,2024-09-19 07:00:00,Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQa0M4b3g4LThibmRENjZLbDVNZXczX2JMc1FLYzIwOWV1dmZ5RE5JUURQdGwzS005c29Vak1qbUhRMXRsV0xkTDFSaENMZGdfaVZUNDNTQ3ZnMXNZQTEycDMzbGVHdVRnbzlQZ3NxT3dGSmNiSjFvaVAwcXpseXRjNlB6QnhGcVIxRkdPT2NYLVR4V1FQSmEtSEJkT2czVXBKZURrcktkWE1VYU5JS3lXaDBzQnJ4dHBXclRwRQ?oc=5"" target=""_blank"">Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMivAFBVV95cUxQa0M4b3g4LThibmRENjZLbDVNZXczX2JMc1FLYzIwOWV1dmZ5RE5JUURQdGwzS005c29Vak1qbUhRMXRsV0xkTDFSaENMZGdfaVZUNDNTQ3ZnMXNZQTEycDMzbGVHdVRnbzlQZ3NxT3dGSmNiSjFvaVAwcXpseXRjNlB6QnhGcVIxRkdPT2NYLVR4V1FQSmEtSEJkT2czVXBKZURrcktkWE1VYU5JS3lXaDBzQnJ4dHBXclRwRQ?oc=5,Google News,Biocon FDA inspection,"Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQa0M4b3g4LThibmRENjZLbDVNZXczX2JMc1FLYzIwOWV1dmZ5RE5JUURQdGwzS005c29Vak1qbUhRMXRsV0xkTDFSaENMZGdfaVZUNDNTQ3ZnMXNZQTEycDMzbGVHdVRnbzlQZ3NxT3dGSmNiSjFvaVAwcXpseXRjNlB6QnhGcVIxRkdPT2NYLVR4V1FQSmEtSEJkT2czVXBKZURrcktkWE1VYU5JS3lXaDBzQnJ4dHBXclRwRQ?oc=5"" target=""_blank"">Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.9660661220550537,negative,0.9660661220550537,0.0,neutral,0.0,-0.4588,0.0,0.118,0.882,0.0,0.16666666666666666,-0.5520377840314592,0.7124330610275269,regulatory_review,0.7077520310878753,['FDA inspection'],False,False,10,0.5155040621757507
2024-09-10,2024-09-10 07:00:00,"FDA issues Form 483s to Japanese, Indian drugmakers in wake of plant inspections - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxNRFZDZXhpX2U1U2RjMHN1c1B2WGY1aVIyNExmOEo5TGE0VDlQTEJfcVVwejNza0JjdTN2Y1I3Qk1jQnZ4cW4zOTRRWjJDTWVjTTNXbl9JUXU3dW9wNGlYSklOR1BOcFlCT3JRLU5xWC1vTkFSSUw4cDJUbXdlUXVCTy05UG1mMzZEVll0LVQ4SnlSWjgwOHZNbV9KRDkyMjlRd1gtX09nRVhZZTA?oc=5"" target=""_blank"">FDA issues Form 483s to Japanese, Indian drugmakers in wake of plant inspections</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiqwFBVV95cUxNRFZDZXhpX2U1U2RjMHN1c1B2WGY1aVIyNExmOEo5TGE0VDlQTEJfcVVwejNza0JjdTN2Y1I3Qk1jQnZ4cW4zOTRRWjJDTWVjTTNXbl9JUXU3dW9wNGlYSklOR1BOcFlCT3JRLU5xWC1vTkFSSUw4cDJUbXdlUXVCTy05UG1mMzZEVll0LVQ4SnlSWjgwOHZNbV9KRDkyMjlRd1gtX09nRVhZZTA?oc=5,Google News,Biocon FDA inspection,"FDA issues Form 483s to Japanese, Indian drugmakers in wake of plant inspections - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxNRFZDZXhpX2U1U2RjMHN1c1B2WGY1aVIyNExmOEo5TGE0VDlQTEJfcVVwejNza0JjdTN2Y1I3Qk1jQnZ4cW4zOTRRWjJDTWVjTTNXbl9JUXU3dW9wNGlYSklOR1BOcFlCT3JRLU5xWC1vTkFSSUw4cDJUbXdlUXVCTy05UG1mMzZEVll0LVQ4SnlSWjgwOHZNbV9KRDkyMjlRd1gtX09nRVhZZTA?oc=5"" target=""_blank"">FDA issues Form 483s to Japanese, Indian drugmakers in wake of plant inspections</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.9095746874809265,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9095746874809265,regulatory_review,0.7665302872657775,['FDA inspection'],False,False,10,0.6330605745315552
2023-08-18,2023-08-18 07:00:00,Another FDA inspection ends in 483 for Biocon in Malaysia - BioProcess International,"<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxNQkJLMk90M3R5dkYybGthQ0ZvcUNOMXRVdDNkYldCYTk4WUw1alpvYTVmRVlyYmRzei12cmx2cEVfTXlKY0ZPMlE5bkEwaFdsM0FacmRxaUFKc2lTRFVnamlWRVJvcnVTREFzTGhDaE8tdTB0UXFOeGxnejkxcF9rT25xZG1FWnhuMVJrN3lEdUhPY2RESTR5MnFiM0FiMjJ5RHc?oc=5"" target=""_blank"">Another FDA inspection ends in 483 for Biocon in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxNQkJLMk90M3R5dkYybGthQ0ZvcUNOMXRVdDNkYldCYTk4WUw1alpvYTVmRVlyYmRzei12cmx2cEVfTXlKY0ZPMlE5bkEwaFdsM0FacmRxaUFKc2lTRFVnamlWRVJvcnVTREFzTGhDaE8tdTB0UXFOeGxnejkxcF9rT25xZG1FWnhuMVJrN3lEdUhPY2RESTR5MnFiM0FiMjJ5RHc?oc=5,Google News,Biocon FDA inspection,"Another FDA inspection ends in 483 for Biocon in Malaysia - BioProcess International <a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxNQkJLMk90M3R5dkYybGthQ0ZvcUNOMXRVdDNkYldCYTk4WUw1alpvYTVmRVlyYmRzei12cmx2cEVfTXlKY0ZPMlE5bkEwaFdsM0FacmRxaUFKc2lTRFVnamlWRVJvcnVTREFzTGhDaE8tdTB0UXFOeGxnejkxcF9rT25xZG1FWnhuMVJrN3lEdUhPY2RESTR5MnFiM0FiMjJ5RHc?oc=5"" target=""_blank"">Another FDA inspection ends in 483 for Biocon in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",0.0,neutral,0.8516349792480469,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8516349792480469,regulatory_review,0.7379916131496429,['FDA inspection'],False,True,15,0.5759832262992859
2024-08-05,2024-08-05 07:00:00,Biocon gets US FDA report after Vizag facility scan; no more regulatory action needed - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets US FDA report after Vizag facility scan; no more regulatory action needed</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon gets US FDA report after Vizag facility scan; no more regulatory action needed - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets US FDA report after Vizag facility scan; no more regulatory action needed</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.9117307662963867,0.0,neutral,0.0,-0.5267,0.0,0.121,0.879,-0.06000000000000001,0.24000000000000005,0.0,0.4994769220987956,regulatory_issues,0.6655054926872254,['regulatory action'],False,True,14,0.5310109853744507
2024-06-15,2024-06-15 07:00:00,Biocon API facility in Visakhapatnam receives 3 observations from USFDA inspection - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon API facility in Visakhapatnam receives 3 observations from USFDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon API facility in Visakhapatnam receives 3 observations from USFDA inspection - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon API facility in Visakhapatnam receives 3 observations from USFDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.6728252172470093,positive,0.6728252172470093,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3844715527125767,0.6728252172470093,regulatory_review,0.6502508789300918,['FDA inspection'],False,True,15,0.4005017578601837
2023-10-18,2023-10-18 07:00:00,Biocon shares fall most in three months as Malaysia unit may face approval delays post USFDA inspection - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMizAFBVV95cUxQdDdzTTJzM3JrVERWUGNWenRvMGFJX0xZaVJ4Y1gzZk82Tm02bTNqdFNWNDY1eTM3NXVYU01lMWxhMFcwTmxUOU1QVUdtejFPbS1tR19uTmhHVk1VTk1WY1RUbk1US21tcjIwb0Z4R0ZHRDJYODduRTZCUGcwbVRSRXNVazBGRF9oSDVhdnBBejFmdi02cm1QSnktT2dfOUwyWlFKdHlud19zWlI4WTBHSlY0ZFpjMEpOdTdyaGllazVBWGJOLUlIT0owZEbSAdIBQVVfeXFMTXhhX1dyT25JTWRUY2wwTWRIUFVGajBzbmh3amdpVUVMQ0dwYk5PTFRTSThsNHhYOWEzQmNiOUhRRzB0UURkRlNDcWNuY3VMa3ExMEdrQzhkN3NicGszcFQ4OUhLX2lVRGJmLTRrc0RkZ0tPeF9OTk5IdGx2Mi13NFRzUnRGUU1DenYydVJ1ckh6RFFKcHVMc19lZjhuRGtreFlIZkdBQ2sycTJVb244eGloMFlxSWgyOExhQ25jQ05lQW5MbkxyUndpYmZHRHJmMkxR?oc=5"" target=""_blank"">Biocon shares fall most in three months as Malaysia unit may face approval delays post USFDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon shares fall most in three months as Malaysia unit may face approval delays post USFDA inspection - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall most in three months as Malaysia unit may face approval delays post USFDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",-0.9671845436096191,negative,0.9671845436096191,0.0,neutral,0.0,0.8625,0.227,0.0,0.773,0.3333333333333333,0.3333333333333333,-0.5526768820626395,0.7210059589809842,regulatory_review,0.5959022462368011,['FDA inspection'],False,True,15,0.2918044924736023
2025-06-27,2025-06-27 04:58:53,Biocon Biologics: A Visionary Play on the $13B Eylea® Market with Yesafili™'s Canadian Approval and Global Ambitions - AInvest,"<a href=""https://news.google.com/rss/articles/CBMixgFBVV95cUxNSm1GRVRhRzFkMFhWLTJtNHNTY2pxWUM1dUprN1UyWG84X01kdjRJNHFpa0xRMy1YNVFiNW1SQmh3UnhSNjZMWHVnaFEyOE8tMXpvTUtLRnEyRXdyZUtMUTJuU2RJaXhjVkstWjN2Q2hyN3J6c0VwRVhiM081anJtdkoyVWJib1FMY3FDZW1oU3Fld2tPQkN4Q1BLSzV4LUExWjNHU0VNbEdxRExCcTVjNlQ1NjdKTzIzbUw0TzVsVi1SZlpXWlE?oc=5"" target=""_blank"">Biocon Biologics: A Visionary Play on the $13B Eylea® Market with Yesafili™'s Canadian Approval and Global Ambitions</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AInvest</font>",https://news.google.com/rss/articles/CBMixgFBVV95cUxNSm1GRVRhRzFkMFhWLTJtNHNTY2pxWUM1dUprN1UyWG84X01kdjRJNHFpa0xRMy1YNVFiNW1SQmh3UnhSNjZMWHVnaFEyOE8tMXpvTUtLRnEyRXdyZUtMUTJuU2RJaXhjVkstWjN2Q2hyN3J6c0VwRVhiM081anJtdkoyVWJib1FMY3FDZW1oU3Fld2tPQkN4Q1BLSzV4LUExWjNHU0VNbEdxRExCcTVjNlQ1NjdKTzIzbUw0TzVsVi1SZlpXWlE?oc=5,Google News,Biocon regulatory approval,"Biocon Biologics: A Visionary Play on the $13B Eylea® Market with Yesafili™'s Canadian Approval and Global Ambitions - AInvest <a href=""https://news.google.com/rss/articles/CBMixgFBVV95cUxNSm1GRVRhRzFkMFhWLTJtNHNTY2pxWUM1dUprN1UyWG84X01kdjRJNHFpa0xRMy1YNVFiNW1SQmh3UnhSNjZMWHVnaFEyOE8tMXpvTUtLRnEyRXdyZUtMUTJuU2RJaXhjVkstWjN2Q2hyN3J6c0VwRVhiM081anJtdkoyVWJib1FMY3FDZW1oU3Fld2tPQkN4Q1BLSzV4LUExWjNHU0VNbEdxRExCcTVjNlQ1NjdKTzIzbUw0TzVsVi1SZlpXWlE?oc=5"" target=""_blank"">Biocon Biologics: A Visionary Play on the $13B Eylea® Market with Yesafili™'s Canadian Approval and Global Ambitions</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AInvest</font>",0.6630027294158936,positive,0.6630027294158936,0.0,neutral,0.0,0.9501,0.372,0.0,0.628,0.0,0.0,0.37885870252336773,0.8065513647079467,approval_process,0.8079403638839722,['FDA approval'],False,True,16,0.6158807277679443
2025-05-27,2025-05-27 07:00:00,Biocon Biologics receives MHRA approval for YESINTEK - European Pharmaceutical Manufacturer,"<a href=""https://news.google.com/rss/articles/CBMi-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?oc=5"" target=""_blank"">Biocon Biologics receives MHRA approval for YESINTEK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">European Pharmaceutical Manufacturer</font>",https://news.google.com/rss/articles/CBMi-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?oc=5,Google News,Biocon regulatory approval,"Biocon Biologics receives MHRA approval for YESINTEK - European Pharmaceutical Manufacturer <a href=""https://news.google.com/rss/articles/CBMi-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?oc=5"" target=""_blank"">Biocon Biologics receives MHRA approval for YESINTEK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">European Pharmaceutical Manufacturer</font>",0.8589955568313599,positive,0.8589955568313599,0.0,neutral,0.0,0.7351,0.237,0.0,0.763,0.0,0.0,0.4908546039036342,0.79704777841568,approval_process,0.8183872997760773,['FDA approval'],False,True,16,0.6367745995521545
2025-01-07,2025-01-07 08:00:00,"Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.8767358064651489,positive,0.8767358064651489,0.0,neutral,0.0,0.7351,0.171,0.0,0.829,0.0,0.0,0.5009918894086565,0.8059179032325745,approval_process,0.7158581614494324,['drug approval'],False,True,16,0.43171632289886475
2025-04-28,2025-04-28 07:00:00,"Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals - Equitypandit","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNU1ZBMkczS3B4SWZ5WGVoVzBWcmNqUHdkTU53MXdTSFVBaWdMMFZyUW42NE5NRjc4Z0NudGItQnNqdFVEc3lkZmpQVF96RFlnY0dpdlkzRkphRkZTUkNKd2xOSEJvdXpMaW9Wc3VmOGJLeEdndmpmQjFhakpfbTlvRWJiRDBiMTNwSE9rcVVRa1ZJREdXYkVyb3MydkYyNkU2RzJyN2NEN0hBNHNMUVRvejctem5uVUt6SkE?oc=5"" target=""_blank"">Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxNU1ZBMkczS3B4SWZ5WGVoVzBWcmNqUHdkTU53MXdTSFVBaWdMMFZyUW42NE5NRjc4Z0NudGItQnNqdFVEc3lkZmpQVF96RFlnY0dpdlkzRkphRkZTUkNKd2xOSEJvdXpMaW9Wc3VmOGJLeEdndmpmQjFhakpfbTlvRWJiRDBiMTNwSE9rcVVRa1ZJREdXYkVyb3MydkYyNkU2RzJyN2NEN0hBNHNMUVRvejctem5uVUt6SkE?oc=5,Google News,Biocon regulatory approval,"Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals - Equitypandit <a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNU1ZBMkczS3B4SWZ5WGVoVzBWcmNqUHdkTU53MXdTSFVBaWdMMFZyUW42NE5NRjc4Z0NudGItQnNqdFVEc3lkZmpQVF96RFlnY0dpdlkzRkphRkZTUkNKd2xOSEJvdXpMaW9Wc3VmOGJLeEdndmpmQjFhakpfbTlvRWJiRDBiMTNwSE9rcVVRa1ZJREdXYkVyb3MydkYyNkU2RzJyN2NEN0hBNHNMUVRvejctem5uVUt6SkE?oc=5"" target=""_blank"">Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",0.9370501637458801,positive,0.9370501637458801,0.0,neutral,0.0,0.7906,0.273,0.0,0.727,0.19999999999999998,0.3333333333333333,0.5354572364262172,0.64255005458196,approval_process,0.7697956264019012,['regulatory approval'],False,True,16,0.5395912528038025
2025-04-11,2025-04-11 07:00:00,"Biocon Shares in Focus, Strengthens US Oncology Footprint with Biosimilar Approval - Groww","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxOR195WnVUMnhKeVg3Sk16NmFQbkY3cDU1QlE1eEUzV1dmdmtmRkRuNFAwRWptdFJuNG4xdFJrYU5JWWZTSm9vTzZfZHhkdWhIcjhSU1FDOWVwa0JXWnBPMGNNenlkWEhYaW1zZ1d4c0VkUUJkaUwyc3FFZnBzVjZBMGtsLWRydGw5ZkhMbFdFTFJleHVKTnFCdlViZXcxdw?oc=5"" target=""_blank"">Biocon Shares in Focus, Strengthens US Oncology Footprint with Biosimilar Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Groww</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxOR195WnVUMnhKeVg3Sk16NmFQbkY3cDU1QlE1eEUzV1dmdmtmRkRuNFAwRWptdFJuNG4xdFJrYU5JWWZTSm9vTzZfZHhkdWhIcjhSU1FDOWVwa0JXWnBPMGNNenlkWEhYaW1zZ1d4c0VkUUJkaUwyc3FFZnBzVjZBMGtsLWRydGw5ZkhMbFdFTFJleHVKTnFCdlViZXcxdw?oc=5,Google News,Biocon regulatory approval,"Biocon Shares in Focus, Strengthens US Oncology Footprint with Biosimilar Approval - Groww <a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxOR195WnVUMnhKeVg3Sk16NmFQbkY3cDU1QlE1eEUzV1dmdmtmRkRuNFAwRWptdFJuNG4xdFJrYU5JWWZTSm9vTzZfZHhkdWhIcjhSU1FDOWVwa0JXWnBPMGNNenlkWEhYaW1zZ1d4c0VkUUJkaUwyc3FFZnBzVjZBMGtsLWRydGw5ZkhMbFdFTFJleHVKTnFCdlViZXcxdw?oc=5"" target=""_blank"">Biocon Shares in Focus, Strengthens US Oncology Footprint with Biosimilar Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Groww</font>",0.9288952946662903,positive,0.9288952946662903,0.0,neutral,0.0,0.91,0.391,0.0,0.609,0.0,0.0,0.5307973112378802,0.9194476473331452,approval_process,1.0,"['FDA approval', 'biosimilar approval']",False,True,16,0.6001510620117188
2025-04-11,2025-04-11 07:00:00,Biocon Share Price Rises 5.5% After USFDA Approval For JOBEVNE Biosimilar - Samco,"<a href=""https://news.google.com/rss/articles/CBMiwgFBVV95cUxOT2tPSFdjb2k4bFdmQ1ozeG95NkpOcG5DcGFxZDRUazJEVExuaUluYTkwc1NyLUlySHVIR2tWWUJEaUZfZV9jbS05Vk9HTUhJM1BQVUpkTVF4b253SlY1NWwyYU5XSHhSSDloZTZUNGJLSEhrbXMtOEduX25kTUV6ZE9QdFNSM3J5YjdRWjJuSEhqWDdDZDZWUGd4WWIxU0pTVU5jMXJQMTRfNDVGd2xIamRLdVdIT3FOT2VYMVNheERwdw?oc=5"" target=""_blank"">Biocon Share Price Rises 5.5% After USFDA Approval For JOBEVNE Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Samco</font>",https://news.google.com/rss/articles/CBMiwgFBVV95cUxOT2tPSFdjb2k4bFdmQ1ozeG95NkpOcG5DcGFxZDRUazJEVExuaUluYTkwc1NyLUlySHVIR2tWWUJEaUZfZV9jbS05Vk9HTUhJM1BQVUpkTVF4b253SlY1NWwyYU5XSHhSSDloZTZUNGJLSEhrbXMtOEduX25kTUV6ZE9QdFNSM3J5YjdRWjJuSEhqWDdDZDZWUGd4WWIxU0pTVU5jMXJQMTRfNDVGd2xIamRLdVdIT3FOT2VYMVNheERwdw?oc=5,Google News,Biocon regulatory approval,"Biocon Share Price Rises 5.5% After USFDA Approval For JOBEVNE Biosimilar - Samco <a href=""https://news.google.com/rss/articles/CBMiwgFBVV95cUxOT2tPSFdjb2k4bFdmQ1ozeG95NkpOcG5DcGFxZDRUazJEVExuaUluYTkwc1NyLUlySHVIR2tWWUJEaUZfZV9jbS05Vk9HTUhJM1BQVUpkTVF4b253SlY1NWwyYU5XSHhSSDloZTZUNGJLSEhrbXMtOEduX25kTUV6ZE9QdFNSM3J5YjdRWjJuSEhqWDdDZDZWUGd4WWIxU0pTVU5jMXJQMTRfNDVGd2xIamRLdVdIT3FOT2VYMVNheERwdw?oc=5"" target=""_blank"">Biocon Share Price Rises 5.5% After USFDA Approval For JOBEVNE Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Samco</font>",0.936037003993988,positive,0.936037003993988,0.0,neutral,0.0,0.8625,0.325,0.0,0.675,0.0,0.0,0.5348782879965646,0.899268501996994,approval_process,0.7589389681816101,['FDA approval'],False,True,16,0.5178779363632202
2025-01-07,2025-01-07 08:00:00,"Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.8878949880599976,positive,0.8878949880599976,0.0,neutral,0.0,0.9468,0.42,0.0,0.58,0.0,0.0,0.5073685646057129,0.9173474940299988,approval_process,0.7213665246963501,['drug approval'],False,True,16,0.4427330493927002
2022-11-16,2022-11-16 08:00:00,Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMimAJBVV95cUxPbURCZFZkaDZYMG4yaWNOVEp5Y25pYUhXYS1EZTVjazZiekw3TnRCT291Yk5UZTVraWlraDJuNUZ1bGR2NUxpS0VpR21QQ0d4dzRMcWswVU1QWGNqSmNRVllFSGZuRVhnVHVOSE1CdWlXeXdZM25FNFp0ZGhEbHRSSkRxb3ROQ0JsVldxcTZwdGtRdF9FTld3VnRUekEtUHd1SjZON19LWlVBbzhJWjlkdzlUak9BcDZUSnUwYXR2djBST3ByNnFFOGlIU1NJRXlBN2ZZN21FOFVwSXVSLTRUZ1huWXJWc3lWX0x2NzRSUDNoelhreXFvTWJlSVdKejU1aVA4YnEyQnNWMTQwQ2J1MHNFVmd2R0FO0gGeAkFVX3lxTFBZVkViaGpRQ3E5SXg5bVlOZUQzdkRYYms0bzF5MkhxbmVBRVRzbG5GREtoSm4zNXV2ekJzU1pCQ0lTQXczLUxVbHdlTVIzNEYySzdYUllSbDRzYktGaVlkU2JEZndycWhtVC1zTnJ1WDFXcF9vRXJ6VFRvckl1MFV1QnI2OVZsenA0Zks4RjFpZWhOa0NVNE9JaFYtcktKN182TUFWcEdyU1RZSWYwZVRXbENkNkxPV0dwMXRpMjZWTGVxVWFyaWFOTXpjVDZjQ3hGWUFWNjdwS2s3amF5MTBGUjhaQ214QTRTeGpzNkx4NGd3OWlxUkRLSS1ULXBINllSb0ZQeU9OaEVxbEFiblVhRlpFMmxMQVoxQ2Q5TXc?oc=5,Google News,Biocon regulatory approval,"Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.7135533094406128,positive,0.7135533094406128,0.0,neutral,0.0,0.5574,0.141,0.0,0.859,0.13333333333333333,0.13333333333333333,0.4077447482517787,0.46809554759131533,approval_process,1.0,"['regulatory approval', 'FDA approval', 'drug approval', 'biosimilar approval', 'interchangeable designation', 'marketing authorization', 'FDA clearance']",False,True,21,0.730959415435791
2025-04-28,2025-04-28 07:00:00,Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA - Trade Brains,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPMjNlVFpucURuR0NYN1RwalhfbEd6T3Y3M0NvX2NfdExPUGJPRGJjV0RxWjBVUjg5ZzBDUVFZanJtUHlsZ1YzQ1RrcFF0T2NDeFFHcUR2cF9zaUlrMDkyZTZ2YmhuMmR1dUtEd0xXNHNoUmtVSDdHbnk4aW1UQ2Y5SDJtakc3RjE4VUx1Rnd4cnpxcng3Rjk5RElfVy1tbU9kYWNZSWhKTjN0Mmpodmc?oc=5"" target=""_blank"">Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxPMjNlVFpucURuR0NYN1RwalhfbEd6T3Y3M0NvX2NfdExPUGJPRGJjV0RxWjBVUjg5ZzBDUVFZanJtUHlsZ1YzQ1RrcFF0T2NDeFFHcUR2cF9zaUlrMDkyZTZ2YmhuMmR1dUtEd0xXNHNoUmtVSDdHbnk4aW1UQ2Y5SDJtakc3RjE4VUx1Rnd4cnpxcng3Rjk5RElfVy1tbU9kYWNZSWhKTjN0Mmpodmc?oc=5,Google News,Biocon regulatory approval,"Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA - Trade Brains <a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPMjNlVFpucURuR0NYN1RwalhfbEd6T3Y3M0NvX2NfdExPUGJPRGJjV0RxWjBVUjg5ZzBDUVFZanJtUHlsZ1YzQ1RrcFF0T2NDeFFHcUR2cF9zaUlrMDkyZTZ2YmhuMmR1dUtEd0xXNHNoUmtVSDdHbnk4aW1UQ2Y5SDJtakc3RjE4VUx1Rnd4cnpxcng3Rjk5RElfVy1tbU9kYWNZSWhKTjN0Mmpodmc?oc=5"" target=""_blank"">Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",0.931842029094696,positive,0.931842029094696,0.0,neutral,0.0,0.5574,0.141,0.0,0.859,0.0,0.0,0.5324811594826834,0.744621014547348,approval_process,0.729274794459343,['regulatory approval'],False,False,11,0.4585495889186859
2025-05-27,2025-05-27 07:00:00,Biocon Biologics receives MHRA approval for Yesintek - The Pharma Letter,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxOTklGZGlyYnJKb1VEZXRfQ1dZaFhrcnBNX0ZkR2FUY1hEVzJnemdsRTJaZV9ZUzB6U3FqWEdHbzZDOU5KWnA3MERxUTZfSHkzc25WVVh3ams5YTByUDRRTlJlTHpKaDVndkhXQjdCVzVWRGx0azBLZWkyQVFseTNFZF82VjRpNjVaTWdSczNReWZTRkxHTk1oWElVMUs?oc=5"" target=""_blank"">Biocon Biologics receives MHRA approval for Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Pharma Letter</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxOTklGZGlyYnJKb1VEZXRfQ1dZaFhrcnBNX0ZkR2FUY1hEVzJnemdsRTJaZV9ZUzB6U3FqWEdHbzZDOU5KWnA3MERxUTZfSHkzc25WVVh3ams5YTByUDRRTlJlTHpKaDVndkhXQjdCVzVWRGx0azBLZWkyQVFseTNFZF82VjRpNjVaTWdSczNReWZTRkxHTk1oWElVMUs?oc=5,Google News,Biocon regulatory approval,"Biocon Biologics receives MHRA approval for Yesintek - The Pharma Letter <a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxOTklGZGlyYnJKb1VEZXRfQ1dZaFhrcnBNX0ZkR2FUY1hEVzJnemdsRTJaZV9ZUzB6U3FqWEdHbzZDOU5KWnA3MERxUTZfSHkzc25WVVh3ams5YTByUDRRTlJlTHpKaDVndkhXQjdCVzVWRGx0azBLZWkyQVFseTNFZF82VjRpNjVaTWdSczNReWZTRkxHTk1oWElVMUs?oc=5"" target=""_blank"">Biocon Biologics receives MHRA approval for Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Pharma Letter</font>",0.6265360713005066,positive,0.6265360713005066,0.0,neutral,0.0,0.7351,0.237,0.0,0.763,0.0,0.0,0.35802061217171804,0.6808180356502533,approval_process,0.8091680705547333,['FDA approval'],False,True,16,0.6183361411094666
2022-06-21,2022-06-21 07:00:00,Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval - outlookbusiness.com,"<a href=""https://news.google.com/rss/articles/CBMi-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?oc=5"" target=""_blank"">Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">outlookbusiness.com</font>",https://news.google.com/rss/articles/CBMi-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?oc=5,Google News,Biocon regulatory approval,"Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval - outlookbusiness.com <a href=""https://news.google.com/rss/articles/CBMi-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?oc=5"" target=""_blank"">Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">outlookbusiness.com</font>",0.0,neutral,0.8866255283355713,0.0,neutral,0.0,-0.3612,0.087,0.157,0.756,0.0,0.0,0.0,0.6239127641677856,approval_process,0.8242462277412415,['drug approval'],False,True,16,0.6484924554824829
2022-06-22,2022-06-22 07:00:00,Product approvals legitimate: Biocon after CBI detains CDSCO officials in kickback case - Medical Dialogues,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOXzB3RUJSTENoQkRnaHZTekxaUmtDNlpZOGxqRDg4clhBQ3BhZXVsbTg0N0dnVktLS2pVRWFuVUxPelZJZ2gyZHN0TUI0eXRORldNTXdaSjNEcFVXRGdEWEpxM2h3N3IteFFBbWo1bHZDV1JLQmIxZlJfelN1Rm4wUnBqQUFOMkhyWDZGbFR5U2RiS1pBenVyMjhDYi1fMXJ2UDhDOUpjZ1hKZXdURVJUWXdFMTg2aHc5RUotUlN1NDVKUElGMW9YRzlRNmtXWDBzZGFhNnFYN2_SAd4BQVVfeXFMTnZWLVBGZldIc0FHMEt3ZjlTajhaMllXOWpxOGJOZG9YdG5XY1QwcEhZb2RyckJfdW44SU9raHJPRDNid21jNTBYcDhsd2VQRk5xdnM5LW1uQXM2YVRkcVRjMkRFR21Ob2JlUGRCSklFWFh6Z2xhYVBRS2RMYVB2UXd2UWs4enZEMEpYODdRa2c3bDVKVDhYVnlXNmVNNkh0azFjV2J3dlZGMkctd1YxTDNnWDIxOUZZMkFneEppWE1oam04aEN4ZXdnTUx5a1BrdDVPM0t2NU5PZVNKTllR?oc=5"" target=""_blank"">Product approvals legitimate: Biocon after CBI detains CDSCO officials in kickback case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxOXzB3RUJSTENoQkRnaHZTekxaUmtDNlpZOGxqRDg4clhBQ3BhZXVsbTg0N0dnVktLS2pVRWFuVUxPelZJZ2gyZHN0TUI0eXRORldNTXdaSjNEcFVXRGdEWEpxM2h3N3IteFFBbWo1bHZDV1JLQmIxZlJfelN1Rm4wUnBqQUFOMkhyWDZGbFR5U2RiS1pBenVyMjhDYi1fMXJ2UDhDOUpjZ1hKZXdURVJUWXdFMTg2aHc5RUotUlN1NDVKUElGMW9YRzlRNmtXWDBzZGFhNnFYN2_SAd4BQVVfeXFMTnZWLVBGZldIc0FHMEt3ZjlTajhaMllXOWpxOGJOZG9YdG5XY1QwcEhZb2RyckJfdW44SU9raHJPRDNid21jNTBYcDhsd2VQRk5xdnM5LW1uQXM2YVRkcVRjMkRFR21Ob2JlUGRCSklFWFh6Z2xhYVBRS2RMYVB2UXd2UWs4enZEMEpYODdRa2c3bDVKVDhYVnlXNmVNNkh0azFjV2J3dlZGMkctd1YxTDNnWDIxOUZZMkFneEppWE1oam04aEN4ZXdnTUx5a1BrdDVPM0t2NU5PZVNKTllR?oc=5,Google News,Biocon regulatory approval,"Product approvals legitimate: Biocon after CBI detains CDSCO officials in kickback case - Medical Dialogues <a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOXzB3RUJSTENoQkRnaHZTekxaUmtDNlpZOGxqRDg4clhBQ3BhZXVsbTg0N0dnVktLS2pVRWFuVUxPelZJZ2gyZHN0TUI0eXRORldNTXdaSjNEcFVXRGdEWEpxM2h3N3IteFFBbWo1bHZDV1JLQmIxZlJfelN1Rm4wUnBqQUFOMkhyWDZGbFR5U2RiS1pBenVyMjhDYi1fMXJ2UDhDOUpjZ1hKZXdURVJUWXdFMTg2aHc5RUotUlN1NDVKUElGMW9YRzlRNmtXWDBzZGFhNnFYN2_SAd4BQVVfeXFMTnZWLVBGZldIc0FHMEt3ZjlTajhaMllXOWpxOGJOZG9YdG5XY1QwcEhZb2RyckJfdW44SU9raHJPRDNid21jNTBYcDhsd2VQRk5xdnM5LW1uQXM2YVRkcVRjMkRFR21Ob2JlUGRCSklFWFh6Z2xhYVBRS2RMYVB2UXd2UWs4enZEMEpYODdRa2c3bDVKVDhYVnlXNmVNNkh0azFjV2J3dlZGMkctd1YxTDNnWDIxOUZZMkFneEppWE1oam04aEN4ZXdnTUx5a1BrdDVPM0t2NU5PZVNKTllR?oc=5"" target=""_blank"">Product approvals legitimate: Biocon after CBI detains CDSCO officials in kickback case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",-0.829997181892395,negative,0.829997181892395,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-0.47428410393851145,0.829997181892395,approval_process,0.780775398015976,['drug approval'],False,True,16,0.5615507960319519
2025-01-07,2025-01-07 08:00:00,Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval - theafricalogistics.com,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOcEQzSWd0LU5iZmkyMjFqLVpodzdyWVBVc3JhbjhoMHNBRUViYlB3aS14YmRicF80VDU3d01QUGF1M0tPcnpXMGs2UWZONmljTHlKOW02MkhoYzc0WXlxR0huRmpiM1ZqdGtnMXFqN05hYTZEeXg1cWtKZ2pZRTZfai1WajlpUzBUX2NFcHNuNXdEMUdhaUFMRkR1bFhLTEoyOWU3b0RTWGMxXzVvU0E?oc=5"" target=""_blank"">Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theafricalogistics.com</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxOcEQzSWd0LU5iZmkyMjFqLVpodzdyWVBVc3JhbjhoMHNBRUViYlB3aS14YmRicF80VDU3d01QUGF1M0tPcnpXMGs2UWZONmljTHlKOW02MkhoYzc0WXlxR0huRmpiM1ZqdGtnMXFqN05hYTZEeXg1cWtKZ2pZRTZfai1WajlpUzBUX2NFcHNuNXdEMUdhaUFMRkR1bFhLTEoyOWU3b0RTWGMxXzVvU0E?oc=5,Google News,Biocon regulatory approval,"Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval - theafricalogistics.com <a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOcEQzSWd0LU5iZmkyMjFqLVpodzdyWVBVc3JhbjhoMHNBRUViYlB3aS14YmRicF80VDU3d01QUGF1M0tPcnpXMGs2UWZONmljTHlKOW02MkhoYzc0WXlxR0huRmpiM1ZqdGtnMXFqN05hYTZEeXg1cWtKZ2pZRTZfai1WajlpUzBUX2NFcHNuNXdEMUdhaUFMRkR1bFhLTEoyOWU3b0RTWGMxXzVvU0E?oc=5"" target=""_blank"">Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theafricalogistics.com</font>",0.835119903087616,positive,0.835119903087616,0.0,neutral,0.0,0.7579,0.263,0.0,0.737,0.0,0.06666666666666667,0.47721137319292345,0.796509951543808,approval_process,0.7522668242454529,['regulatory approval'],False,True,16,0.5045336484909058
2024-06-24,2024-06-24 07:00:00,Biocon Biologics Receives EMA Approval for New Biosimilar Facility - newskarnataka.com,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxOVkg4Z2c3bWp6N2pCTzVxMlBUXzNHTkIwNjgzRmZHazhsdExKNV9sYjQ5Q3NJWm5KbXpBMUk5MHRUbWlSZUxWOEc5Um1ETzZLMTBLWk9ZXzI4MUU1aDVuV2pxTnBfR3V5M01BUlJreFVpVjRxdkllY1FIcldSQ2ZvanNnVm1yQ1Rzb1gzZm9LTUFSa3hwNEw3YUh2dno5WUJBcVByc3hSc1dmbGRRMTV3?oc=5"" target=""_blank"">Biocon Biologics Receives EMA Approval for New Biosimilar Facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">newskarnataka.com</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxOVkg4Z2c3bWp6N2pCTzVxMlBUXzNHTkIwNjgzRmZHazhsdExKNV9sYjQ5Q3NJWm5KbXpBMUk5MHRUbWlSZUxWOEc5Um1ETzZLMTBLWk9ZXzI4MUU1aDVuV2pxTnBfR3V5M01BUlJreFVpVjRxdkllY1FIcldSQ2ZvanNnVm1yQ1Rzb1gzZm9LTUFSa3hwNEw3YUh2dno5WUJBcVByc3hSc1dmbGRRMTV3?oc=5,Google News,Biocon insulin biosimilar,"Biocon Biologics Receives EMA Approval for New Biosimilar Facility - newskarnataka.com <a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxOVkg4Z2c3bWp6N2pCTzVxMlBUXzNHTkIwNjgzRmZHazhsdExKNV9sYjQ5Q3NJWm5KbXpBMUk5MHRUbWlSZUxWOEc5Um1ETzZLMTBLWk9ZXzI4MUU1aDVuV2pxTnBfR3V5M01BUlJreFVpVjRxdkllY1FIcldSQ2ZvanNnVm1yQ1Rzb1gzZm9LTUFSa3hwNEw3YUh2dno5WUJBcVByc3hSc1dmbGRRMTV3?oc=5"" target=""_blank"">Biocon Biologics Receives EMA Approval for New Biosimilar Facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">newskarnataka.com</font>",0.6617307662963867,positive,0.6617307662963867,0.0,neutral,0.0,0.7351,0.237,0.0,0.763,0.0909090909090909,0.30303030303030304,0.37813186645507807,0.4959132857351592,approval_process,1.0,"['FDA approval', 'drug approval', 'biosimilar approval', 'interchangeable designation', 'marketing authorization', 'regulatory approval', 'FDA clearance']",False,True,21,0.7133358716964722
2024-12-02,2024-12-02 08:00:00,Biocon Shares Rally 4% as Subsidiary Receives USFDA Approval - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxNaFJkbmZMcXBWSTBXcktrelhhbnBDOEFjMkRmRzg4M0Z3VmZxRjFhekc4U21YRmlvNUtmSG5tRDN4OVVyVV9MZDdpNkJrSnZvV2ZaTDRsZ3JsR2s3VUFoRW5YWWRaMEdqWEdPckpRaGhkamF6UmRSNllKWWlub1BVVEFWaHVJMGlNNzZQWWotbS1tOGM?oc=5"" target=""_blank"">Biocon Shares Rally 4% as Subsidiary Receives USFDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxNaFJkbmZMcXBWSTBXcktrelhhbnBDOEFjMkRmRzg4M0Z3VmZxRjFhekc4U21YRmlvNUtmSG5tRDN4OVVyVV9MZDdpNkJrSnZvV2ZaTDRsZ3JsR2s3VUFoRW5YWWRaMEdqWEdPckpRaGhkamF6UmRSNllKWWlub1BVVEFWaHVJMGlNNzZQWWotbS1tOGM?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"Biocon Shares Rally 4% as Subsidiary Receives USFDA Approval - Equitypandit <a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxNaFJkbmZMcXBWSTBXcktrelhhbnBDOEFjMkRmRzg4M0Z3VmZxRjFhekc4U21YRmlvNUtmSG5tRDN4OVVyVV9MZDdpNkJrSnZvV2ZaTDRsZ3JsR2s3VUFoRW5YWWRaMEdqWEdPckpRaGhkamF6UmRSNllKWWlub1BVVEFWaHVJMGlNNzZQWWotbS1tOGM?oc=5"" target=""_blank"">Biocon Shares Rally 4% as Subsidiary Receives USFDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",0.9109441041946411,positive,0.9109441041946411,0.0,neutral,0.0,0.7579,0.283,0.0,0.717,0.0,0.0,0.5205394881112235,0.8344220520973206,approval_process,0.7370373159646988,['FDA approval'],False,True,16,0.4740746319293976
2022-03-14,2022-03-14 07:00:00,Niramai receives FDA clearance for SMILE-100 System - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Niramai receives FDA clearance for SMILE-100 System</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"Niramai receives FDA clearance for SMILE-100 System - ET HealthWorld <a href=""https://news.google.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?oc=5"" target=""_blank"">Niramai receives FDA clearance for SMILE-100 System</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",0.7774776220321655,positive,0.7774776220321655,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.4442729268755231,0.7774776220321655,approval_process,0.8167530596256256,['FDA clearance'],False,False,11,0.6335061192512512
2025-04-10,2025-04-10 07:00:00,FDA Approves Biocon’s Avastin Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxOMHFSOXp6VmFjWTRHYV9uai1FV1FVcHB6dHgxT25ZWVBVem55cUtYMmRRa19pUEhjQUNNeUw2aE9qaDJtLVlkMWdRaUU1d1FEbm9IbWp5NHdkUndJZm44Nnlja0hfd0VFT1c0WVdLOExtaU5PYlJjWnZsM2c4dDN3YkxhVzNvUkM3a0R0cEVmaDJidw?oc=5"" target=""_blank"">FDA Approves Biocon’s Avastin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxOMHFSOXp6VmFjWTRHYV9uai1FV1FVcHB6dHgxT25ZWVBVem55cUtYMmRRa19pUEhjQUNNeUw2aE9qaDJtLVlkMWdRaUU1d1FEbm9IbWp5NHdkUndJZm44Nnlja0hfd0VFT1c0WVdLOExtaU5PYlJjWnZsM2c4dDN3YkxhVzNvUkM3a0R0cEVmaDJidw?oc=5,Google News,Biocon biosimilarity study,"FDA Approves Biocon’s Avastin Biosimilar - Managed Healthcare Executive <a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxOMHFSOXp6VmFjWTRHYV9uai1FV1FVcHB6dHgxT25ZWVBVem55cUtYMmRRa19pUEhjQUNNeUw2aE9qaDJtLVlkMWdRaUU1d1FEbm9IbWp5NHdkUndJZm44Nnlja0hfd0VFT1c0WVdLOExtaU5PYlJjWnZsM2c4dDN3YkxhVzNvUkM3a0R0cEVmaDJidw?oc=5"" target=""_blank"">FDA Approves Biocon’s Avastin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",0.5403483510017395,positive,0.5403483510017395,0.0,neutral,0.0,0.6597,0.252,0.0,0.748,0.0,0.0,0.3087704862867083,0.6000241755008697,approval_process,0.8434768915176392,['FDA approval'],False,True,16,0.6869537830352783
2024-12-02,2024-12-02 08:00:00,"FDA Approves Biocon Biologics Ustekinumab Biosimilar, Yesintek - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxOMVVUc0JjMzRfeWZuWUJWS1B5cl9XQi1CZ3ZkZVVJVHEtR3hrbHRKUnpRR25lSzJyQjJqc2VCVlo2N2QwZk0yUkZWY1I4dDNObkFDVEN3Z3hMdXNTNGNuY0lQZ3B4VXFRUm9kNWIzdlc4ZnJSVGNOVGlINHk5MjNJVXNfb1FOYmd5UTNFSkpHU1l5bUl6ZUNPUzdoTzlKVmQtTXppNFhB?oc=5"" target=""_blank"">FDA Approves Biocon Biologics Ustekinumab Biosimilar, Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxOMVVUc0JjMzRfeWZuWUJWS1B5cl9XQi1CZ3ZkZVVJVHEtR3hrbHRKUnpRR25lSzJyQjJqc2VCVlo2N2QwZk0yUkZWY1I4dDNObkFDVEN3Z3hMdXNTNGNuY0lQZ3B4VXFRUm9kNWIzdlc4ZnJSVGNOVGlINHk5MjNJVXNfb1FOYmd5UTNFSkpHU1l5bUl6ZUNPUzdoTzlKVmQtTXppNFhB?oc=5,Google News,Biocon biosimilarity study,"FDA Approves Biocon Biologics Ustekinumab Biosimilar, Yesintek - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxOMVVUc0JjMzRfeWZuWUJWS1B5cl9XQi1CZ3ZkZVVJVHEtR3hrbHRKUnpRR25lSzJyQjJqc2VCVlo2N2QwZk0yUkZWY1I4dDNObkFDVEN3Z3hMdXNTNGNuY0lQZ3B4VXFRUm9kNWIzdlc4ZnJSVGNOVGlINHk5MjNJVXNfb1FOYmd5UTNFSkpHU1l5bUl6ZUNPUzdoTzlKVmQtTXppNFhB?oc=5"" target=""_blank"">FDA Approves Biocon Biologics Ustekinumab Biosimilar, Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.7611715793609619,0.0,neutral,0.0,0.6597,0.213,0.0,0.787,-0.05,0.05,0.0,0.49029052645365395,approval_process,1.0,"['FDA approval', 'drug approval', 'biosimilar approval', 'interchangeable designation', 'marketing authorization', 'regulatory approval', 'FDA clearance']",False,True,21,0.716026246547699
2024-05-21,2024-05-21 07:00:00,Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S. Ophthalmology Market - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxOeGRuOEpEaURCa1IyQjZsSzkydERHN2VJYmdHSm1pZFRhMFN4SzdJcDZCVERQbHZJQVczVVJjQUFQNXNyZWpLLTBiVjhuMUhwWWZkVHVPNjlUUUh0X3RHQTAxdHE0WHdhdGVJWDZ5U0ZVMzZydjMxRmtWUng3OWFQSFpIUmw4ME1MYjNiNHEtOEd5aUtFRDh3N3dvd0xfQmNSQmRMNFcxV2ZyWlZFUEFxNUdIOHFMWktOMFgyLTJmVC1pUWxwQUVjVEJVS2xiNnhTRWJCSEZUNzFBbzdCNHNVWTZhMFJqNzYwa0gxVTRBRUlQVmVuZUxFajNKcw?oc=5"" target=""_blank"">Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S. Ophthalmology Market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi-wFBVV95cUxOeGRuOEpEaURCa1IyQjZsSzkydERHN2VJYmdHSm1pZFRhMFN4SzdJcDZCVERQbHZJQVczVVJjQUFQNXNyZWpLLTBiVjhuMUhwWWZkVHVPNjlUUUh0X3RHQTAxdHE0WHdhdGVJWDZ5U0ZVMzZydjMxRmtWUng3OWFQSFpIUmw4ME1MYjNiNHEtOEd5aUtFRDh3N3dvd0xfQmNSQmRMNFcxV2ZyWlZFUEFxNUdIOHFMWktOMFgyLTJmVC1pUWxwQUVjVEJVS2xiNnhTRWJCSEZUNzFBbzdCNHNVWTZhMFJqNzYwa0gxVTRBRUlQVmVuZUxFajNKcw?oc=5,Google News,Biocon biosimilarity study,"Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S. Ophthalmology Market - PR Newswire <a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxOeGRuOEpEaURCa1IyQjZsSzkydERHN2VJYmdHSm1pZFRhMFN4SzdJcDZCVERQbHZJQVczVVJjQUFQNXNyZWpLLTBiVjhuMUhwWWZkVHVPNjlUUUh0X3RHQTAxdHE0WHdhdGVJWDZ5U0ZVMzZydjMxRmtWUng3OWFQSFpIUmw4ME1MYjNiNHEtOEd5aUtFRDh3N3dvd0xfQmNSQmRMNFcxV2ZyWlZFUEFxNUdIOHFMWktOMFgyLTJmVC1pUWxwQUVjVEJVS2xiNnhTRWJCSEZUNzFBbzdCNHNVWTZhMFJqNzYwa0gxVTRBRUlQVmVuZUxFajNKcw?oc=5"" target=""_blank"">Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S. Ophthalmology Market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.6510518789291382,positive,0.6510518789291382,0.0,neutral,0.0,0.7351,0.154,0.0,0.846,0.0,0.0,0.37202964510236464,0.6930759394645691,approval_process,0.8232651948928833,['FDA approval'],False,True,16,0.6465303897857666
2024-12-02,2024-12-02 08:00:00,"FDA Approves Sixth Ustekinumab Biosimilar, Yesintek - AJMC","<a href=""https://news.google.com/rss/articles/CBMiggFBVV95cUxQNXRQRjFDQTJ4ak1zSzllem55U0tINW1iRmRJckY3djJYN2ZZMGJpT0hVNVM2TVRDQXN3YzFYYkViQ2V1ZHQ1YjRHUXBlUnN3Mkc2OTZ2aUo1U1hHMElya0M2dTFlNTlnaC0tSWtkaWxwa3p4X3VuQjRVcmNrUFRUVDZ3?oc=5"" target=""_blank"">FDA Approves Sixth Ustekinumab Biosimilar, Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",https://news.google.com/rss/articles/CBMiggFBVV95cUxQNXRQRjFDQTJ4ak1zSzllem55U0tINW1iRmRJckY3djJYN2ZZMGJpT0hVNVM2TVRDQXN3YzFYYkViQ2V1ZHQ1YjRHUXBlUnN3Mkc2OTZ2aUo1U1hHMElya0M2dTFlNTlnaC0tSWtkaWxwa3p4X3VuQjRVcmNrUFRUVDZ3?oc=5,Google News,Biocon biosimilarity study,"FDA Approves Sixth Ustekinumab Biosimilar, Yesintek - AJMC <a href=""https://news.google.com/rss/articles/CBMiggFBVV95cUxQNXRQRjFDQTJ4ak1zSzllem55U0tINW1iRmRJckY3djJYN2ZZMGJpT0hVNVM2TVRDQXN3YzFYYkViQ2V1ZHQ1YjRHUXBlUnN3Mkc2OTZ2aUo1U1hHMElya0M2dTFlNTlnaC0tSWtkaWxwa3p4X3VuQjRVcmNrUFRUVDZ3?oc=5"" target=""_blank"">FDA Approves Sixth Ustekinumab Biosimilar, Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",0.0,neutral,0.6054099202156067,0.0,neutral,0.0,0.6597,0.278,0.0,0.722,0.0,0.0,0.0,0.6325549601078033,approval_process,0.8384490013122559,['FDA approval'],False,False,11,0.6768980026245117
2025-04-24,2025-04-24 07:00:00,Biosimilars Market Expansion in 2025: The Next Big Thing - openPR.com,"<a href=""https://news.google.com/rss/articles/CBMilgFBVV95cUxNenlqNGQ3MVdoS0RCT1hoMGpUNVhNcUdBOHpKbldTd2I3NlpMTHJDWnMySzVZTTliSHdNRklHcjA0RldrOC1qWHZ3UU5kNEJyOTFXOFJJazVJb2VvY3hxUUk5d0x4blprMk9OQVlXVV9WQU9PLVBqUkF5M2Y4UWdtMkltMHdyRjBHV0FJZzN2cjRKdmVPSUE?oc=5"" target=""_blank"">Biosimilars Market Expansion in 2025: The Next Big Thing</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",https://news.google.com/rss/articles/CBMilgFBVV95cUxNenlqNGQ3MVdoS0RCT1hoMGpUNVhNcUdBOHpKbldTd2I3NlpMTHJDWnMySzVZTTliSHdNRklHcjA0RldrOC1qWHZ3UU5kNEJyOTFXOFJJazVJb2VvY3hxUUk5d0x4blprMk9OQVlXVV9WQU9PLVBqUkF5M2Y4UWdtMkltMHdyRjBHV0FJZzN2cjRKdmVPSUE?oc=5,Google News,Biocon market expansion,"Biosimilars Market Expansion in 2025: The Next Big Thing - openPR.com <a href=""https://news.google.com/rss/articles/CBMilgFBVV95cUxNenlqNGQ3MVdoS0RCT1hoMGpUNVhNcUdBOHpKbldTd2I3NlpMTHJDWnMySzVZTTliSHdNRklHcjA0RldrOC1qWHZ3UU5kNEJyOTFXOFJJazVJb2VvY3hxUUk5d0x4blprMk9OQVlXVV9WQU9PLVBqUkF5M2Y4UWdtMkltMHdyRjBHV0FJZzN2cjRKdmVPSUE?oc=5"" target=""_blank"">Biosimilars Market Expansion in 2025: The Next Big Thing</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",0.0,neutral,0.8369675874710083,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.04,0.0,0.8369675874710083,post_approval,0.4940561532974243,['market expansion'],False,False,7,0.38811230659484863
2025-02-11,2025-02-11 08:00:00,Biocon betting big on new product launches for growth - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon betting big on new product launches for growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Biocon betting big on new product launches for growth - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon betting big on new product launches for growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.7709921598434448,0.0,neutral,0.0,0.3818,0.094,0.0,0.906,0.09610389610389611,0.21558441558441557,0.0,0.41629868531578024,post_approval,0.5287696450948716,['product launch'],False,True,12,0.45753929018974304
2024-12-02,2024-12-02 08:00:00,Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels - topnews.in,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1p0dkQwbWFUZzN3YkVzclVDOUFRQ3hCM0NYUEU2S3QzZl9PVHk3RFR6WUlfWkY4dHZrTjhDRWh0WEZTS25Cck16aHVCSWRNZVRIcEV1SmdnR3NZQ1FRa3I5REhhc05WOVVyTTNlV05JaWdobUQ3M0Y4bTk2RjN3YjgwcnpDY0l2MTNiZlFzTjVpOTBRaGtuRnVmZU56Y1dDbE1za0owVmJlay0zRTFhdzIxWlpJR1NvRUE?oc=5"" target=""_blank"">Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1p0dkQwbWFUZzN3YkVzclVDOUFRQ3hCM0NYUEU2S3QzZl9PVHk3RFR6WUlfWkY4dHZrTjhDRWh0WEZTS25Cck16aHVCSWRNZVRIcEV1SmdnR3NZQ1FRa3I5REhhc05WOVVyTTNlV05JaWdobUQ3M0Y4bTk2RjN3YjgwcnpDY0l2MTNiZlFzTjVpOTBRaGtuRnVmZU56Y1dDbE1za0owVmJlay0zRTFhdzIxWlpJR1NvRUE?oc=5,Google News,Biocon market expansion,"Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels - topnews.in <a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1p0dkQwbWFUZzN3YkVzclVDOUFRQ3hCM0NYUEU2S3QzZl9PVHk3RFR6WUlfWkY4dHZrTjhDRWh0WEZTS25Cck16aHVCSWRNZVRIcEV1SmdnR3NZQ1FRa3I5REhhc05WOVVyTTNlV05JaWdobUQ3M0Y4bTk2RjN3YjgwcnpDY0l2MTNiZlFzTjVpOTBRaGtuRnVmZU56Y1dDbE1za0owVmJlay0zRTFhdzIxWlpJR1NvRUE?oc=5"" target=""_blank"">Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",0.9212486147880554,positive,0.9212486147880554,0.0,neutral,0.0,0.8625,0.275,0.0,0.725,0.0,0.06666666666666667,0.5264277798788888,0.8918743073940277,approval_process,0.7271521091461182,['FDA approval'],False,True,16,0.45430421829223633
2024-08-30,2024-08-30 07:00:00,Akums Drugs strengthens global presence with European market expansion - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Akums Drugs strengthens global presence with European market expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Akums Drugs strengthens global presence with European market expansion - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Akums Drugs strengthens global presence with European market expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9094298481941223,positive,0.9094298481941223,0.0,neutral,0.0,0.7184,0.214,0.0,0.786,0.0,0.0,0.5196741989680699,0.8139149240970611,post_approval,0.5041160464286805,['market expansion'],False,False,7,0.40823209285736084
2025-06-27,2025-06-27 07:00:23,Rethinking the Future: Nasopharyngeal Cancer Market Expansion - openPR.com,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxPTFRzcF9zdTBlaFl3TG52aEI0Z2JzTDJROEFHLWxWTHZwYk14YUJSbFpYblZDMmlQbE1aN1hnR25wY1hWRnpGU0pkZUxLUmlpdVpBNFJ5TVVSOHdoZUc4cy1jd2lIZFdPc3FWZkUyakVoM0RkUjNEaGtTTmlBZGRiNmRmeHFyY09sd1R0VkN4NUNRbHlfZzVBY1JVM04?oc=5"" target=""_blank"">Rethinking the Future: Nasopharyngeal Cancer Market Expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxPTFRzcF9zdTBlaFl3TG52aEI0Z2JzTDJROEFHLWxWTHZwYk14YUJSbFpYblZDMmlQbE1aN1hnR25wY1hWRnpGU0pkZUxLUmlpdVpBNFJ5TVVSOHdoZUc4cy1jd2lIZFdPc3FWZkUyakVoM0RkUjNEaGtTTmlBZGRiNmRmeHFyY09sd1R0VkN4NUNRbHlfZzVBY1JVM04?oc=5,Google News,Biocon market expansion,"Rethinking the Future: Nasopharyngeal Cancer Market Expansion - openPR.com <a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxPTFRzcF9zdTBlaFl3TG52aEI0Z2JzTDJROEFHLWxWTHZwYk14YUJSbFpYblZDMmlQbE1aN1hnR25wY1hWRnpGU0pkZUxLUmlpdVpBNFJ5TVVSOHdoZUc4cy1jd2lIZFdPc3FWZkUyakVoM0RkUjNEaGtTTmlBZGRiNmRmeHFyY09sd1R0VkN4NUNRbHlfZzVBY1JVM04?oc=5"" target=""_blank"">Rethinking the Future: Nasopharyngeal Cancer Market Expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",0.0,neutral,0.8748514652252197,0.0,neutral,0.0,-0.8689,0.0,0.355,0.645,0.0,0.08333333333333333,0.0,0.8718757326126099,post_approval,0.517023327946663,['market expansion'],False,False,7,0.4340466558933258
2025-01-08,2025-01-08 08:00:00,Biocon Biologics Secures Japan PMDA Approval For Psoriasis Drug - IPO Central,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9QNWtGQ1N6NS14MF9UWTlDdDdrbGt4VDZUTmZYcTM4b3Ntel9BYXBSRXRYdWZWZjlnNzQzOW03dDZyejgwcmFONUIwR1JLTXFieWRaQzVNeFFBRmkxSGs4dTJ5Q21qdDZTVUd3UHkzM3E?oc=5"" target=""_blank"">Biocon Biologics Secures Japan PMDA Approval For Psoriasis Drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IPO Central</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9QNWtGQ1N6NS14MF9UWTlDdDdrbGt4VDZUTmZYcTM4b3Ntel9BYXBSRXRYdWZWZjlnNzQzOW03dDZyejgwcmFONUIwR1JLTXFieWRaQzVNeFFBRmkxSGs4dTJ5Q21qdDZTVUd3UHkzM3E?oc=5,Google News,Biocon market expansion,"Biocon Biologics Secures Japan PMDA Approval For Psoriasis Drug - IPO Central <a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9QNWtGQ1N6NS14MF9UWTlDdDdrbGt4VDZUTmZYcTM4b3Ntel9BYXBSRXRYdWZWZjlnNzQzOW03dDZyejgwcmFONUIwR1JLTXFieWRaQzVNeFFBRmkxSGs4dTJ5Q21qdDZTVUd3UHkzM3E?oc=5"" target=""_blank"">Biocon Biologics Secures Japan PMDA Approval For Psoriasis Drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IPO Central</font>",0.7035807967185974,positive,0.7035807967185974,0.0,neutral,0.0,0.8689,0.351,0.0,0.649,0.0,0.125,0.40204616955348416,0.7862403983592987,approval_process,0.7438861131668091,['FDA approval'],False,True,16,0.48777222633361816
2025-04-02,2025-04-02 19:20:50,Another Cholesterol Drug Has Been Recalled - MSN,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxNaGhnX3kyMjMyN2R3bTh0Q2VFb3c0Z01mLTVZRXZvZ3pCaWhaWldfX3F5MzRkQU5xYzBBSERUVU5lajBRMTJRRU1WaEI1X2VUVzNBZlRKNFpjS2I2c3o2dVlxdVRSQllQQ2h6S1B2WS1CMlRQanZwRldiRnY1QVJMNTJjOEdqUHI3Y3Z1ODRLRDJ1SWwxX2NWTQ?oc=5"" target=""_blank"">Another Cholesterol Drug Has Been Recalled</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxNaGhnX3kyMjMyN2R3bTh0Q2VFb3c0Z01mLTVZRXZvZ3pCaWhaWldfX3F5MzRkQU5xYzBBSERUVU5lajBRMTJRRU1WaEI1X2VUVzNBZlRKNFpjS2I2c3o2dVlxdVRSQllQQ2h6S1B2WS1CMlRQanZwRldiRnY1QVJMNTJjOEdqUHI3Y3Z1ODRLRDJ1SWwxX2NWTQ?oc=5,Google News,Biocon guidance,"Another Cholesterol Drug Has Been Recalled - MSN <a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxNaGhnX3kyMjMyN2R3bTh0Q2VFb3c0Z01mLTVZRXZvZ3pCaWhaWldfX3F5MzRkQU5xYzBBSERUVU5lajBRMTJRRU1WaEI1X2VUVzNBZlRKNFpjS2I2c3o2dVlxdVRSQllQQ2h6S1B2WS1CMlRQanZwRldiRnY1QVJMNTJjOEdqUHI3Y3Z1ODRLRDJ1SWwxX2NWTQ?oc=5"" target=""_blank"">Another Cholesterol Drug Has Been Recalled</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",-0.9301250576972961,negative,0.9301250576972961,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-0.5315000329698835,0.9301250576972961,regulatory_issues,0.6166024297475815,['recall'],False,False,9,0.43320485949516296
2025-06-27,2025-06-27 04:25:07,Biocon Biologics Receives Health Canada Approval for - GlobeNewswire,"<a href=""https://news.google.com/rss/articles/CBMimAJBVV95cUxNOHROdS00MTY2STk2ZHZCOXAtN3otVUtrQmZicmVNcy1XOVhWVW81ck50aVdTcGNLR2EyS2gzbzdBTWhQN1NiZGdVVHpIWVl5bjI4RlA1TzZFWS1td21YQW1pLUZvVjdQZW9qYm5wcE9PN3ZjemNMUnRSamRKdDBrenNOMzdoaHNyLWx6ZVU1a2FKNkxNUFJvUXUxOFIxUDdWbTNDZzRIMTVnUTF1UW1HX2xnaHFwdEQ1SzAtc0g4UHNldlF5b0tYRFF2V2ZCY3BlUGc5MENvUGJEbW9LaGxzbWk0TFdhSDRaNEVGYVFMckVfSjBhYjRhdkNnS0tOQnRlaFVraFY5Nm1PaVg0dVhnQ3AtclVURHpl?oc=5"" target=""_blank"">Biocon Biologics Receives Health Canada Approval for</a>&nbsp;&nbsp;<font color=""#6f6f6f"">GlobeNewswire</font>",https://news.google.com/rss/articles/CBMimAJBVV95cUxNOHROdS00MTY2STk2ZHZCOXAtN3otVUtrQmZicmVNcy1XOVhWVW81ck50aVdTcGNLR2EyS2gzbzdBTWhQN1NiZGdVVHpIWVl5bjI4RlA1TzZFWS1td21YQW1pLUZvVjdQZW9qYm5wcE9PN3ZjemNMUnRSamRKdDBrenNOMzdoaHNyLWx6ZVU1a2FKNkxNUFJvUXUxOFIxUDdWbTNDZzRIMTVnUTF1UW1HX2xnaHFwdEQ1SzAtc0g4UHNldlF5b0tYRFF2V2ZCY3BlUGc5MENvUGJEbW9LaGxzbWk0TFdhSDRaNEVGYVFMckVfSjBhYjRhdkNnS0tOQnRlaFVraFY5Nm1PaVg0dVhnQ3AtclVURHpl?oc=5,Google News,Biocon annual results,"Biocon Biologics Receives Health Canada Approval for - GlobeNewswire <a href=""https://news.google.com/rss/articles/CBMimAJBVV95cUxNOHROdS00MTY2STk2ZHZCOXAtN3otVUtrQmZicmVNcy1XOVhWVW81ck50aVdTcGNLR2EyS2gzbzdBTWhQN1NiZGdVVHpIWVl5bjI4RlA1TzZFWS1td21YQW1pLUZvVjdQZW9qYm5wcE9PN3ZjemNMUnRSamRKdDBrenNOMzdoaHNyLWx6ZVU1a2FKNkxNUFJvUXUxOFIxUDdWbTNDZzRIMTVnUTF1UW1HX2xnaHFwdEQ1SzAtc0g4UHNldlF5b0tYRFF2V2ZCY3BlUGc5MENvUGJEbW9LaGxzbWk0TFdhSDRaNEVGYVFMckVfSjBhYjRhdkNnS0tOQnRlaFVraFY5Nm1PaVg0dVhnQ3AtclVURHpl?oc=5"" target=""_blank"">Biocon Biologics Receives Health Canada Approval for</a>&nbsp;&nbsp;<font color=""#6f6f6f"">GlobeNewswire</font>",0.722179651260376,positive,0.722179651260376,0.0,neutral,0.0,0.7351,0.279,0.0,0.721,0.0,0.0,0.41267408643450054,0.728639825630188,approval_process,0.8051066994667053,['FDA approval'],False,True,16,0.6102133989334106
2025-01-30,2025-01-30 08:00:00,"FDA Reviews Golimumab Biosimilar, Samsung Biologics Hits Record Sales, Japan Approves Stelara Biosimilar - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxQQ29SS0ZTRHJBU2doTXNOVzJ6X0xrYVJYbWhQQkxmNVVFd2U5ZjZJenR0ZGpoN201OERpb3o2cWFMWnJxRzBwblZLaHpXVlRuWEIyeXUxeExQOGN1MTZUaXpwdEw5N2NEeXJzV0hXQ1ZreUJyZkpXVlVia1hfU1BaMFZvbU5fVWhGVkROVjNHUmdRTk1Lc0txRFFwUy1kNUlUcEtxQm1Qcmk0ZGhwVzdvcm1IMkpUVU1Ha2IwWVlTUjRHbTVXVEN2VjdjVDdfb3VpT2tBTzA5WlA1M2Rx?oc=5"" target=""_blank"">FDA Reviews Golimumab Biosimilar, Samsung Biologics Hits Record Sales, Japan Approves Stelara Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMi3AFBVV95cUxQQ29SS0ZTRHJBU2doTXNOVzJ6X0xrYVJYbWhQQkxmNVVFd2U5ZjZJenR0ZGpoN201OERpb3o2cWFMWnJxRzBwblZLaHpXVlRuWEIyeXUxeExQOGN1MTZUaXpwdEw5N2NEeXJzV0hXQ1ZreUJyZkpXVlVia1hfU1BaMFZvbU5fVWhGVkROVjNHUmdRTk1Lc0txRFFwUy1kNUlUcEtxQm1Qcmk0ZGhwVzdvcm1IMkpUVU1Ha2IwWVlTUjRHbTVXVEN2VjdjVDdfb3VpT2tBTzA5WlA1M2Rx?oc=5,Google News,Biocon annual results,"FDA Reviews Golimumab Biosimilar, Samsung Biologics Hits Record Sales, Japan Approves Stelara Biosimilar - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxQQ29SS0ZTRHJBU2doTXNOVzJ6X0xrYVJYbWhQQkxmNVVFd2U5ZjZJenR0ZGpoN201OERpb3o2cWFMWnJxRzBwblZLaHpXVlRuWEIyeXUxeExQOGN1MTZUaXpwdEw5N2NEeXJzV0hXQ1ZreUJyZkpXVlVia1hfU1BaMFZvbU5fVWhGVkROVjNHUmdRTk1Lc0txRFFwUy1kNUlUcEtxQm1Qcmk0ZGhwVzdvcm1IMkpUVU1Ha2IwWVlTUjRHbTVXVEN2VjdjVDdfb3VpT2tBTzA5WlA1M2Rx?oc=5"" target=""_blank"">FDA Reviews Golimumab Biosimilar, Samsung Biologics Hits Record Sales, Japan Approves Stelara Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.6945764422416687,positive,0.6945764422416687,0.0,neutral,0.0,0.6597,0.144,0.0,0.856,-0.05,0.05,0.3969008241380964,0.46809214741388955,regulatory_review,0.7180093646049499,['FDA review'],False,False,10,0.5360187292098999
2025-04-11,2025-04-11 07:00:00,Biocon share price rises 4% on US FDA approval for cancer drug - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price rises 4% on US FDA approval for cancer drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMixAFBVV95cUxORWE4V1JpOWJuQjd4WkJ5UXQ5WlJQcTc2ZlhOYlFBVU9Fank3SFlRdmQzMVdtRTF6d3FLSl9fTlFmLW11ekUwMFNTbUFsNTBLay1raUVWNnl5c2h4U2RuY2pPbmdaOF9RRDF1MEFUYjJtbldzY1pCNmdXaXdFR08xMTBCWUVpTjJTSHQ4cHYzV1Zqb2N3RzY5dm4zZHBXX1dpbmVKVzlHdzdTQ3hSNWZGVGVjQS1rcFRrRGRCNUZuZlZnT3Fr0gHKAUFVX3lxTFB4OVpJd1ZlelNlblRESDNWc2RKbVJ2aHA1RXA4bWhHRzdfanUzY3lRcTVlZVpwWXZuelFDQUhaVFZ0TW9PWEdyRG5SeGJ1QjBZUHlpRDBWZndRUUNzeHJoV2dueU0zcUV5UkZCcldmckpNRWJONF9HZ1pMMkVnb0Y0THIxbkk4N1ZaeW5VTUZWTEllWWhYNC02aF85SDNIU1hOWHprWDBLbDhoYTVvTllvQUlzRjlYWVpCQ1ZyQmdTNEhNcFp1QWRjV2c?oc=5,Google News,Biocon stock price,"Biocon share price rises 4% on US FDA approval for cancer drug - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price rises 4% on US FDA approval for cancer drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.8850592970848083,positive,0.8850592970848083,0.0,neutral,0.0,-0.0516,0.256,0.213,0.531,0.0,0.0,0.5057481697627476,0.46832964854240416,approval_process,0.7613287568092346,['FDA approval'],False,True,16,0.5226575136184692
2024-12-02,2024-12-02 08:00:00,Biocon shares rise 4% after US FDA approves Yesintek - Moneycontrol,"<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxPazJEQlYxR0ZERnNoS3JnbWtIMGg3QXQyMGZrMzY1Q09nRGhpRkxLM0phb2c0SGh3VGtBSzBTSnB1cUdxdmE0QzRPYnJGVmEzLW5MYmlpaUNXVHBKSWtKNm5rT2NVdmJqQThrUTM0TXRtQXMwR0l5UkNqS19SZ0M3b1R3c1JYRENEWEozMjhub2VnQWhwYUcxMndmalBaT2d2VTlCVHFycEFZa1JTTlhTVFQ4MjBfMk3SAbwBQVVfeXFMTmxSS3AtUllhaGZ1eS15Tkx2Q3hna3JxTFhENXZxMEd1dlpra205aUo4T3o0RW1GUFlMYnYwVGlMbmVpa2lnNEJWVE4xVGRodDkwTFY2aE9ockZQcHA1R1FaV0paQlBCWkZzdy1SR1dJRlZac0o1dTFkd2lRMXh6RGtNS0lqWDd1cUdWUmt4NG94MHlIUDNVRUFrMjZJZUJvWUFnZFVpc01VRngzUFdVR3JaUjUyM1ZmZGNHNjQ?oc=5"" target=""_blank"">Biocon shares rise 4% after US FDA approves Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares rise 4% after US FDA approves Yesintek - Moneycontrol <a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxPazJEQlYxR0ZERnNoS3JnbWtIMGg3QXQyMGZrMzY1Q09nRGhpRkxLM0phb2c0SGh3VGtBSzBTSnB1cUdxdmE0QzRPYnJGVmEzLW5MYmlpaUNXVHBKSWtKNm5rT2NVdmJqQThrUTM0TXRtQXMwR0l5UkNqS19SZ0M3b1R3c1JYRENEWEozMjhub2VnQWhwYUcxMndmalBaT2d2VTlCVHFycEFZa1JTTlhTVFQ4MjBfMk3SAbwBQVVfeXFMTmxSS3AtUllhaGZ1eS15Tkx2Q3hna3JxTFhENXZxMEd1dlpra205aUo4T3o0RW1GUFlMYnYwVGlMbmVpa2lnNEJWVE4xVGRodDkwTFY2aE9ockZQcHA1R1FaV0paQlBCWkZzdy1SR1dJRlZac0o1dTFkd2lRMXh6RGtNS0lqWDd1cUdWUmt4NG94MHlIUDNVRUFrMjZJZUJvWUFnZFVpc01VRngzUFdVR3JaUjUyM1ZmZGNHNjQ?oc=5"" target=""_blank"">Biocon shares rise 4% after US FDA approves Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.8606922626495361,positive,0.8606922626495361,0.0,neutral,0.0,0.8316,0.353,0.0,0.647,0.0,0.0,0.49182415008544916,0.846146131324768,approval_process,0.7748345136642456,['FDA approval'],False,True,16,0.5496690273284912
2024-09-02,2024-09-02 07:00:00,Biocon shares gain after arm gets multiple USFDA approval - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain after arm gets multiple USFDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares gain after arm gets multiple USFDA approval - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain after arm gets multiple USFDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.8280218839645386,positive,0.8280218839645386,0.0,neutral,0.0,0.9231,0.457,0.0,0.543,0.0,0.0,0.47315536226545063,0.8755609419822693,approval_process,0.7050805389881134,['FDA approval'],False,True,16,0.4101610779762268
